Introduction {#s1}
============

Cell-fate decisions are controlled, on the one hand, by intercellular signaling and, on the other hand, by intrinsic mechanisms such as epigenetic chromatin modifications. The Notch signaling pathway is a highly conserved and widespread signaling mechanism ([@bib3]; [@bib21]), which has been implicated in key cell-fate decisions such as the decision between proliferation and differentiation ([@bib43]). Notch signaling has also been implicated in cellular reprograming. Upon inhibition of Notch signaling, the oncogenic genes KLF4 and cMyc become dispensable for the generation of induced pluripotent stem cells (iPSCs) from mouse and human keratinocytes ([@bib28]). In this setting, Notch inhibits reprograming. Conversely, Notch signaling promotes transdifferentiation of pancreatic acinar cells to ductal cells ([@bib54]), or the conversion of hepatocytes into biliary cells in liver primary malignancy intrahepatic cholangiocarcinoma (ICC) ([@bib56]). Notch signaling can also affect reprograming in normal development. In *C. elegans*, signaling through the GLP-1 and LIN-12 Notch receptors impedes reprograming during embryogenesis and, during larval development, signaling through LIN-12 is required for the conversion of a rectal epithelial cell into a motorneuron ([@bib30]; [@bib10]).

The role of epigenetic regulators in cell-fate decisions has been studied mostly in pluripotent cells cultured outside of their normal tissue environment ([@bib47]; [@bib60]; [@bib42]; [@bib49]). Therefore, the epigenetic regulation of stem cell identity in intact tissues remains poorly understood. Additionally, the impact of external cues, for example signaling from a stem cell niche to the recipient cell's chromatin remains equally unresolved. By contrast, *C. elegans* has been used as a model to study reprograming in an intact organism ([@bib27]; [@bib17]; [@bib69]; [@bib18]; [@bib9]; [@bib30]; [@bib68]; [@bib53]). In this model, germ cells can be directly reprogrammed into neurons by depleting specific chromatin modifiers such as LIN-53 (Rbbp4/7) or components of PRC2, and by concomitant overexpression of the transcription factor CHE-1, which induces glutamatergic neuronal fate in a process which we refer to as Germ cell Conversion (GeCo) ([@bib63]; [@bib50]).

Here, we identify the Notch signaling pathway as a critical player in this reprograming model. This was unanticipated, since signaling through the Notch receptor GLP-1 (henceforth GLP-1^Notch^) from the somatic gonadal niche is known to maintain germline stem cell/progenitor fate ([@bib34]). To understand this novel, reprograming-promoting role of GLP-1^Notch^, we combined genetics with tissue-specific expression profiling. We identified genes regulated by GLP-1^Notch^, including genes recently shown to maintain the germline stem/progenitor cells ([@bib33]). Additionally, and unexpectedly, we found that many genes activated by GLP-1^Notch^ signaling were also repressed by the cell fate-stabilizing chromatin regulator PRC2. We show that GLP-1^Notch^ and PRC2 have an antagonistic effect on germ cell-fate decisions and demonstrate co-regulation of their common target, *utx-1.* Importantly, UTX-1 is a histone demethylase known to erase the gene-silencing methylation of histone H3 dependent on PRC2 ([@bib45]; [@bib31]; [@bib65]). Thus, we propose that the GLP-1^Notch^--dependent induction of UTX-1 facilitates reprograming by alleviating PRC2-mediated repression of alternative cell fates.

Results {#s2}
=======

GLP-1^Notch^ enhances conversion of germ cells into neuron-like cells {#s2-1}
---------------------------------------------------------------------

Germ cells can be converted into neuronal cells in intact *C. elegans* upon overexpression of the neuronal transcription factor CHE-1, simply by depleting the chromatin modifier LIN-53 ([@bib63]; [@bib50]). This GeCo phenotype can be followed in living animals by monitoring a reporter GFP expressed from the *gcy-5* promoter, which otherwise is induced in glutamatergic ASE neurons ([@bib2]). In contrast to the spontaneous teratomatous differentiation of meiotic germ cells, observed in the absence of specific RNA-binding proteins ([@bib9]; [@bib7]; [@bib62]), GeCo is preferentially observed in the pre-meiotic, proliferating germ cells ([@bib63]; [@bib50]). Consistently, removing the proliferating germ cells, by inhibiting GLP-1^Notch^ signaling, prevents GeCo ([@bib63]). However, because the proliferating germ cells were eliminated, these experiments did not address a possible direct effect of GLP-1^Notch^ signaling on GeCo. We began addressing this issue by examining the gonads of animals carrying the gain-of-function *glp-1* allele (*ar202*) ([@bib51]). These gonads are filled with proliferating germ cells and, upon depleting LIN-53 and overexpressing CHE-1, we observed that significantly more germ cells converted to ASE neurons ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). We refer to this enhanced GeCo as \'GeCo+\'. Detailed quantification revealed that the GeCo+ gonads contained more than twice the number of converted cells ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). The nuclei of these converted cells were reminiscent of neuronal nuclei and the cells displayed axo-dendritic projection ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}), as previously described ([@bib63]; [@bib50]). To confirm that the GeCo enhancement depends on the canonical Notch signaling pathway, rather than an independent function of the GLP-1^Notch ^receptor, we RNAi-depleted the transcriptional effector of GLP-1^Notch^ signaling, LAG-1 ([@bib8]). We exposed animals only after hatching to *lag-1* RNAi in order to avoid sterility, which is caused when animals are subjected to *lag-1* RNAi earlier ([Supplemental file 1](#SD5-data){ref-type="supplementary-material"}). RNAi-mediated knock-down of *lag-1* strongly inhibited GeCo ([Figure 1B](#fig1){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). Importantly, under these experimental conditions, we did not observe any obvious reduction of germ cell numbers ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}), suggesting a proliferation-independent effect of GLP-1^Notch^ signaling on cell-fate conversion. To investigate this further, we tested GeCo efficiency on germ cells proliferating independently of GLP-1^Notch^ signaling. We took advantage of mutants in which, in the absence of two meiosis/differentiation-promoting factors GLD-1 and GLD-2, germ cells proliferate independently of GLP-1^Notch ^([@bib32]). Specifically, we examined GeCo in the loss-of-function *gld-1(q497) gld-2(q485)* mutants, which carried either wild-type *glp-1* or the loss-of-function *glp-1(q175)* allele ([@bib5]). Both mutant combinations have previously been described to have tumorous germlines and impaired meiotic entry ([@bib32]; [@bib25]). In contrast to efficient GeCo observed in the *gld-1(q497) gld-2(q485)* gonads, GeCo was strongly diminished in the *gld-1(q497) gld-2(q485); glp-1(q175)* gonads, despite the ongoing germ cell proliferation ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). Counting the number of germ cells in these gonads revealed only a slight difference (a 15% increase in the numbers in the double vs. triple mutant gonads), suggesting that the strong enhancement of GeCo by GLP-1^Notch^ signaling cannot be explained by the increased number of germ cells ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). Since it has been proposed that dividing cells have a higher propensity for cellular reprograming ([@bib13]; [@bib24]), we also tested whether blocking the cell cycle would affect the observed GeCo enhancement in *glp-1(gf)* gonads. As previously described ([@bib15]; [@bib50]), we used hydroxyurea (HU) treatment to block the cell cycle in the S phase. Blocking the cell cycle by HU did not diminish the GeCo+ phenotype ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). Combined, these results suggest that GLP-1^Notch^ enhances GeCo independently from its role in promoting germ cell proliferation.10.7554/eLife.15477.003Figure 1.GLP-1^Notch^ signaling promotes reprograming of germ cells.(**A**) GLP-1^Notch^ enhances germ cell conversion (GeCo) into neuronal-like cells. Left: Fluorescent (top) and combined fluorescent/differential interference contrast (DIC) micrographs (bottom) of adult animals. All animals ectopically expressed the pro-neuronal transcription factor CHE-1 from a heat-shock promoter. *glp-1(ar202)* is a temperature-sensitive gain-of-function allele of the Notch receptor. Animals were subjected to either mock (control) or *lin-53* RNAi. Reprogrammed cells expressed a GFP reporter driven from the neuronal *gcy-5* promoter (here an in other figures nGFP) and are outlined here and elsewhere in yellow. Any signal outside the outlined region comes from somatic tissues. GeCo**+** indicates animals that displayed a strongly enhanced GeCo phenotype. Scale bars = 10 μm. The cartoons depicting the GeCo and GeCo+ phenotypes are on the top right. The gonads are shaded in grey and GFP-positive converted germ cells are green. Fractions of animals displaying GeCo and GeCo**+** are indicated below. At least 250 animals were quantified per condition. P-values were calculated using Student\'s t-test: p^1^\<0,0001; p^2^=0,0006. Error bars represent SEM. (**B**) The transcriptional effector of the GLP-1^Notch^ signaling pathway, LAG-1, is required for the GLP-1^Notch^--mediated enhancement of GeCo. Left: Fluorescent micrographs of adults expressing CHE-1--induced nGFP as explained above. GeCo is diminished upon the depletion of LAG-1. White dashed lines outline the animal body. Scale bars = 10 μm. Right: The corresponding quantifications. At least 400 animals were quantified per condition. P-values were calculated using Student\'s t-test: p^1^\<0,0001; p^2^=0,0018. Error bars represent SEM. (**C**) GLP-1^Notch^ signaling enhances GeCo independently from germ cell proliferation. Shown are DAPI-stained gonads of *glp-1(ar202)* animals, expressing CHE-1--induced nGFP, treated with either mock or *lin-53* RNAi. Germ cells were counted from the DTC (yellow asterisk) to the turn of the gonad arm (dashed yellow line). 15 gonad arms per condition were counted. Scale bars = 10 μm. Quantifications are on the right. While greatly inhibiting GeCo, *lag-1* RNAi did not change the number of germ cells. P-values were calculated using Student\'s t-test: p^1^=0,89. Error bars represent SEM. (**D**) GLP-1^Notch^ enhances GeCo independently from proliferation. Left: Fluorescent micrographs of adults (with indicated genotypes), expressing CHE-1--induced nGFP. The first panel on the left shows a control, heterozygous (wild-type) *gld-1 gld-2/++; glp-1/+* animal. The other panels show the homozygous *gld-1(q497) gld-2(q485)* mutants, carrying either a loss-of-function (*q175*, center) or a wild-type (right) allele of *glp-1*. Despite proliferating, germ cells in the *gld-1 gld-2; glp-1* gonads have lost the ability to undergo GeCo. Scale bars = 10 μm. Right: the corresponding quantifications. At least 250 animals were quantified per condition. P-values were calculated using Student\'s t-test: p^1^=0,0478; p^2^=0,0201. Error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.003](10.7554/eLife.15477.003)10.7554/eLife.15477.004Figure 1---source data 1.Quantification of GeCo in *glp-1(gf*) and *lag-1* RNAi animals.(**A**) Quantification of GeCo+ phenotype upon RNAi against *lin-53* in *glp-1(ar202)* mutants. (**B**) Quantification of GeCo dependency on LAG-1. (**C**) Quantification of germ cells in *glp-1* (*ar202)* gonads with our without *lag-1* RNAi treatment. (**D**) Quantification of GeCo in different genetic backgrounds with highly proliferative germlines upon RNAi against *lin-53*. [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"} source data: Quantification of gfp-positive germ cells. [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} source data: Quantification of germ cells in different genetic backgrounds with highly proliferative germlines. [Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"} source data: Quantification of GeCo after cell cycle block with HU treatment. More details can be found in the corresponding figure legends.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.004](10.7554/eLife.15477.004)10.7554/eLife.15477.005Figure 1---figure supplement 1.*glp-1(gf)* gonads contain more than twice the number of converted cells which display neuronal characteristics.(**A**) For the quantification of *gcy-5::gfp*-positive cells per gonadal arm only the GeCo category of *wt* vs. *glp-1(gf)* was used because GeCo**+** animals already show an extensive area of the gonad filled with *gcy-5::gfp*-positive cells with usually \>100 cells/gonad making reliable counting impossible. Notably, animals with a seemingly similar extend of GeCo in *wt* vs. *glp-1(gf)* show a clear increase of *gcy-5::gfp*-positive cells per gonadal arm from approx. 10 in *wt* to \> 30 in *glp-1(gf).* n(wt) = 75 gonaldal arms, n (*glp-1(ar202)*) = 221 gonadal arms. The background of the loss of function allele *glp-1(q175)* leads to a significant decrease in GeCo as shown previously ([@bib63]). (**B**) A magnified view of *gcy-5::gfp*-positive (nGFP) cells, in a GeCo+ gonad from a *glp-1(gf)* animal. The converted cells show axo-dendritic projections (white arrow heads). The inset in the corresponding DIC image, magnified in the right-bottom corner, shows the nuclear morphology of a converted germ cell, which has lost the germ cell-specific 'fried-egg'-like shape and instead shows nuclear speckles characteristic of a neuronal cell. Scale bar = 1 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.005](10.7554/eLife.15477.005)10.7554/eLife.15477.006Figure 1---figure supplement 2.Germ cell numbers are similar between *gld-1 gld-2* double and *gld-1 gld-2*; *glp-1* triple mutants.DAPI-stained gonads of *gld-1(q497) gld-2(q485)* or *gld-1(q497) gld-2(q485); glp-1(q175)* mutants, carrying the *hsp::che-1* and *gcy-5::gfp* transgenes. The gonads were imaged by fluorescent microscopy using Z-stack acquisitions. Germ cells from the DTCs (yellow asterisks) to the turn of the gonad arm (dashed lines) were counted. Below:15 gonad arms per condition of L4 animals were counted. The numbers of germ cells differ only slightly (15%) in the double mutant vs. triple mutants background. Scale bars = 10 μm. Error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.006](10.7554/eLife.15477.006)10.7554/eLife.15477.007Figure 1---figure supplement 3.Blocking the cell cycle with hydroxyurea does not inhibit GeCo+.(**A**) We used hydroxyurea (HU) treatment for 5 hr to chemically block the cell cycle, which makes germ cells arrest in the S phase of the cell cycle. This arrest does not diminish the GeCo+ phenotype in *glp-1(gf)* gonads upon *lin-53* RNAi and *che-1(oe)*. At least 150 animals were quantified per condition. P-values were calculated using Student\'s t-test: p^1^=0,1409; p^2^=0,4583. Error bars represent SEM. The right panel shows examples of GeCo+ displaying animals based on *gcy-5::gfp* (nGFP) for HU-untreated (-HU) and HU-treated (+HU) animals. (**B**) The gonads were stained for EdU incorporation. Dashed lines outline gonads. Asterisks indicate distal tips of gonads. Scale bars = 10 μm. (**C**) The gonads of *glp-1(ar202) gf* animals, which were treated with HU for 12 hr and stained with DAPI and H3Ser10ph (pH3) antibody. The pH3-positive cells indicate condensed chromosomes of dividing cells. After 12 hr of HU treatment, the gonads contained, as expected, enlargement nuclei (arrowheads) ([@bib19]; [@bib15]). The loss of pH3-positive cells indicates a cell cycle arrest. Asterisks indicate distal tips of gonads, dashed lines outline gonad. Scale bars = 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.007](10.7554/eLife.15477.007)

GLP-1^Notch^ activates genes mainly on X chromosomes {#s2-2}
----------------------------------------------------

To understand the effects of GLP-1^Notch^ on GeCo, we set out to identify genes regulated by GLP-1^Notch^ signaling in germ cells. To conduct the analysis in morphologically similar tissue, we again took advantage of the *gld-1 gld-2* double mutants that, combined with either loss-of-function or gain-of-function *glp-1* alleles, have morphologically similar gonads, filled with proliferating, undifferentiated germ cells ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) ([@bib32]; [@bib25]). We combined *gld-1(q497) gld-2(q485)* mutations with either the temperature-sensitive loss-of-function (lf) *glp-1* allele (*e2144)*, or the temperature-sensitive gain-of-function (gf) *glp-1* allele (*ar202)* ([@bib52]; [@bib51]). Because GLD-1 and GLD-2 regulate gene expression at the posttranscriptional level only, we expected that transcriptionally regulated GLP-1^Notch^ targets could be identified in this background.

To analyze gene expression, gonads were dissected from animals grown at the restrictive temperature in two independent experiments, and transcripts were analyzed with tiling arrays (GEO accession number GSE49395). We identified around 100 transcripts that were differentially expressed between the *gld-1 gld-2; glp-1*(lf) (Notch OFF) and *gld-1 gld-2; glp-1*(gf) (Notch ON) gonads ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). These changes were confirmed by quantitative RT-PCR (RT-qPCR) on selected transcripts ([Figure 2---figure supplement2A](#fig2){ref-type="fig"}, [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). Most differentially expressed transcripts were upregulated in the 'Notch ON' gonads, indicating a predominantly activating role of GLP-1^Notch^ in germ cells. For simplicity, we will refer to the transcripts upregulated at least two fold in the Notch ON gonads as 'Notch--activated'. Some Notch-activated genes, such as *sel-8/Mastermind*, *lst-1,* and *epn-1*/*Epsin*, have been implicated in Notch signaling in other cell types ([@bib11]; [@bib67]; [@bib61]; [@bib59]; [@bib33]). However, it remains possible that, rather than being direct GLP-1^Notch^ targets, some of the Notch-activated genes were upregulated as an indirect consequence of increased GLP-1^Notch^ signaling.10.7554/eLife.15477.008Figure 2.GLP-1^Notch^ and PRC2 regulate common targets and are functionally connected.(**A**) Notch-activated genes are biased for the sex chromosome linkage. Left: Changes in transcript abundance in the 'Notch ON' versus 'OFF' dissected gonads (genotypes explained in [Figure 2---figure supplement 1A--B](#fig2s1){ref-type="fig"}) were analyzed by microarrays. Transcripts upregulated at least 2-fold in the 'Notch ON' gonads are marked in red, those downregulated at least 2-fold in blue. Selected transcripts verified by RT-qPCR in [Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"} are additionally circled in black. Right: 5426 genes can be considered expressed in the gonad, based on the bimodal distribution of expression values. Only 3% of those expressed genes are X-linked. In contrast, nearly half (46%) of the expressed and Notch-activated transcripts are X-linked (see [Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"} for numbers). (**B**) GLP-1^Notch^ and PRC2 interact genetically. Left: DAPI-stained gonads from animals of the indicated genotypes. The *mes-2(bn11)* M+Z- single mutant gonads have wild-type appearance at 20°C. The *glp-1(ar202)* gain-of-function mutants have an almost wild-type appearance at this temperature, except for an extended proliferative zone in the gonad, referred to as \'distal tumor\'. At the same temperature, *mes-2(bn11)* M+Z-; *glp-1(ar202)* double mutants developed germline tumors in 32/32 of the examined gonads. The insets show close-ups from the indicated gonadal regions: the distal-most regions contain undifferentiated, proliferative germ cells in all mutants (**a**, **c**, **e**). However, while the single mutants contain oocytes with characteristically condensed chromosomes in the proximal gonads (**b**, **d**), the proximal gonads of the double mutants harbor proliferative germ cells (**f**). Scale bar = 30 μm. Right: quantification of the phenotypes. \'Distal tumor\' indicates the presence of an elongated distal proliferative zone (approximately ½ of the distal gonad arm). \'Extended\' tumor indicates an extended distal tumor, few oocytes, and frequently also a proximal tumor. \'Fully tumorous\' indicates the absence of all differentiated cell types except for sperm produced during larval development. (**C**) GLP-1^Notch^ and PRC2 target the same genes on the X chromosomes. The plots correlate changes in gene expression in M+Z- *mes-2* mutants with changes in gene expression changes in M+Z- *mes-6* mutants. Results are shown separately for X-linked (left) and autosomal (right) transcripts. Notch-activated genes (red in [Figure 2A](#fig2){ref-type="fig"}) are marked in red. Lightly shaded areas indicate transcripts that are at least 2-fold upregulated. The overlap between transcripts upregulated by GLP-1^Notch^ and transcripts upregulated by the loss of CePRC2 is highly significant, particularly for the X-linked genes. The significance of the correlation was measured by hypergeometric distribution; X-linked Notch-activated vs. *mes-2* derepressed: p=1.31e-31; X-linked Notch-activated vs. *mes-6* de-repressed: p=7.41e-25; autosomal Notch-activated vs. *mes-2* derepressed: p=1.47e-22; autosomal Notch-activated vs. *mes-6* de-repressed: p=1.8e-12.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.008](10.7554/eLife.15477.008)10.7554/eLife.15477.009Figure 2---source data 1.Microarray results.(**A**) Microarray results of differentially expressed genes in Notch ON/OFF gonads. [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"} source data: Quantification of germlines with wild-type morphology versus germlines with tumors upon germline-autonomous RNAi against genetic interactors of PRC2. More details can be found in the corresponding figure legends.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.009](10.7554/eLife.15477.009)10.7554/eLife.15477.010Figure 2---figure supplement 1.Examining transcriptional effects of GLP-1^Notch^ signaling.(**A**) GLP-1^Notch^ signaling counteracts the meiosis-promoting activity of several RNA binding proteins, of which GLD-1 and -2 are indicated. (**B**) Mutants that were used in this study: while the loss-of-function (lf) alleles of *glp-1* cause the loss of germ cells, gain-of-function (gf) alleles result in a constitutive proliferation of germ cells. However, in the absence of the meiosis-promoting GLD-1 and GLD-2 proteins, germ cells continue to proliferate in the absence of GLP-1^Notch^ activity. (**C**) Three representative gonads of Notch ON: *gld-2(q497) gld-1(q485); glp-1(ar202)* and Notch OFF: *gld-2(a497) gld-1(q485); glp-1(e2144)* animals are shown after dissection and DAPI staining. The central planes of the gonads were imaged. Nuclei were counted from those images using the CellCounter plugin with ImageJ. For each genetic background, germ cells in the entire gonad of 10 dissected gonads were counted. The quantification below revealed that the numbers of germ cells in both backgrounds are not changed. Error bars represent SD. Scale bar = 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.010](10.7554/eLife.15477.010)10.7554/eLife.15477.011Figure 2---figure supplement 2.Analysis of Notch**-**activated genes.(**A**) Changes in the abundance of several transcripts (marked black in [Figure 2A](#fig2){ref-type="fig"}) were verified independently from the genomic quantification by RT-qPCR. Colors correspond to fold-changes detected by microarrays (green), by RT-qPCR on genetically identical gonads (black), or by RT-qPCR on gonads with a different loss-of-function *glp-1* allele, *q175* (white). \*This experiment was performed only once. The error bars represent SEM. (**B**) Although the number of genes on the arrays is almost equally distributed between the different chromosomes, the expression of X-linked genes is largely silenced in the germline. The table displays the numbers and fractions of genes on the different chromosomes, and the distributions of the Notch-activated genes. The cutoff between \'not expressed\' and \'expressed\' genes was set according to the bimodal distribution of expression values in the Notch ON and OFF arrays.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.011](10.7554/eLife.15477.011)10.7554/eLife.15477.012Figure 2---figure supplement 3.The PRC2 component MES-6 and most enhancers/suppressors of *glp-1(ar202)* induced tumors appear to interact genetically with GLP-1^Notch^ signaling in a germline-autonomous manner.Each bar indicates the relative proportion of germlines with wild-type morphology (grey), germlines that contain eggs but also a proximal or distal tumor (red), and germlines that are fully tumorous (black). \'n\' indicates the number of DAPI-stained gonads scored for each column. Empty vector 1--3 represent three independent replicates of the empty vector control and demonstrate the robustness of the experiment. We observed that, for an unknown reason, the *rrf-1(pk1417); glp-1(ar202)* double mutants were less likely to produce tumors at the semi-permissive temperature of 20°C. Nonetheless, the double mutant strain reacts to enhancers, suppressors, and depletion of PRC2 components in a similar manner as the *glp-1(ar202)* single mutant strain, with the exception of *mbk-1* and B0416.5 RNAi. Depletion of *mes-2* and *mes-3* by RNAi was ineffective, since it did not enhance the tumourous phenotype in either of the two strains.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.012](10.7554/eLife.15477.012)10.7554/eLife.15477.013Figure 2---figure supplement 4.Global levels of H3K27me3 are unaffected by neither loss-of-function nor gain-of-function mutations in *glp-1.*Stainings of wild-type, gain-of-function *glp-1(ar202)*, Notch ON (*gld-2(q497) gld-1(q485); glp-1(ar202)*) and Notch OFF (*gld-2(a497) gld-1(q485); glp-1(q175)*) gonads with antibodies against H3K27me3 performed on whole worms (left panel, scale bars = 10 μm) or dissected gonads (right panel, scale bars = 1 μm). The H3K27me3 levels do not differ globally between the different mutant backgrounds. Asterisks indicate distal tips of gonads, dashed lines outline gonad.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.013](10.7554/eLife.15477.013)

To demonstrate that Notch-activated genes are functionally relevant for germ cell proliferation, we performed RNAi knockdown of Notch-activated genes (n = 64) on animals carrying the gain-of-function *glp-1(ar202)* allele, and screened for enhancement or suppression of the tumorous gonad phenotype ([Supplementary file 1](#SD5-data){ref-type="supplementary-material"}; for detailed experimental procedure see Materials and Methods). Knocking down some of the Notch-activated genes suppressed the tumorous phenotype, which agrees with predominantly proliferation-promoting role of GLP-1^Notch^. Interestingly, knocking down a smaller subset of the Notch-activated genes enhanced the tumor ([Supplementary file 1](#SD5-data){ref-type="supplementary-material"}), suggesting that some of the Notch-activated genes may counteract proliferation. While some of these genes may function autonomously in the germline, others could affect the germline indirectly from the soma. To test this, we RNAi-depleted selected candidates in the *rrf-1 (pk1417)* mutant background, which is permissive for RNAi in the germline but deficient in RNAi in many (but not all) somatic tissues ([@bib36]). While depleting most candidates in the *rrf-1* background had similar effects on the germline as in the wild type (suggesting germline-autonomous function), in some cases the effects were abolished, suggesting that these genes function in the soma ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}, [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}).

Strikingly, we noticed that Notch-activated genes were enriched on the X-chromosome, the *C. elegans* sex chromosome. 45% of the Notch-activated genes were X-linked, which is four-fold more than expected by chance (p=2.99e^-14^; [Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}, [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). When analyzing only genes with higher than baseline germline expression values, the disproportional X-linkage of Notch-activated genes was even more striking (fifteen times more than expected by chance (p=2,19e^-38^; [Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}, [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). In the *C. elegans* germline, X-linked genes are largely silenced by the *C. elegans* PRC2 ([@bib14]). Thus, the X chromosome bias among Notch-activated genes suggested a possible antagonistic relationship between GLP-1^Notch^ and PRC2.

GLP-1^Notch^ and PRC2 have antagonistic functions in the germline {#s2-3}
-----------------------------------------------------------------

The *C. elegans* PRC2 consists of MES-2, -3, and -6 ([@bib6]) and levels of the corresponding transcripts were essentially not altered by GLP-1^Notch^ signaling (*mes-2*: absolute fold change (fc) -1.3747; *mes-3*: fc 1.003; *mes-6*: fc 1.037). To test for a functional relationship between GLP-1^Notch^ and PRC2, we examined genetic interactions between GLP-1 and PRC2 mutants. At 20°C, both the temperature-sensitive gain-of-function *glp-1(ar202)* and the homozygous loss-of-function *mes-2(bn11)* mutants, derived from heterozygous mothers providing maternal MES-2 (*mes-2* M+Z- mutants), were viable and produced gonads with nearly wild-type appearance. The double *mes-2* M+Z-; *glp-1(ar202)* mutants, however, displayed distal and proximal tumors at the same temperature ([Figure 2B](#fig2){ref-type="fig"}; 32/32 examined gonads). PRC2 and GLP-1^Notch^ thus interact functionally, and they appear to do so in a germ cell autonomous manner ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}, [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}).

Given the striking enrichment of Notch-activated genes on the X chromosome, and the genetic interaction between PRC2 and GLP-1^Notch^, we speculated that GLP-1^Notch^ and PRC2 act on similar genes. To determine whether Notch-activated genes are also PRC2-repressed, we first determined putative PRC2 targets by expression analyses on isolated wild-type, M+Z- *mes-2* or *mes-6* mutant gonads (GEO accession number GSE49395). Consistent with the joint function of MES-2 and MES-6 in the PRC2 complex, a very similar set of genes was upregulated upon the loss of either protein ([Figure 2C](#fig2){ref-type="fig"}; [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}; henceforth 'PRC2 repressed' genes; also see ([@bib20]). Indeed, those PRC2-repressed genes overlapped strongly with Notch-activated genes, particularly those linked to the X chromosome. Nearly all of the X-linked Notch-activated genes were also derepressed upon the loss of PRC2 ([Figure 2C](#fig2){ref-type="fig"}). This is consistent with the observed genetic interaction and suggests that increased GLP-1^Notch^ signaling can induce expression of specific PRC2-repressed genes. This activation of the PRC2-repressed genes is not due to a global loss of the repressive tri-methylation of Histone H3 at lysine residue 27 (H3K27me3), since, upon examining gonads of different GLP-1^Notch^ mutants, we observed no global loss of H3K27me3 in the germline ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}).

GLP-1^Notch^ signaling enhances reprograming {#s2-4}
--------------------------------------------

Germ cell conversion to neurons can be triggered not only by LIN-53 depletion but also by the depletion of PRC2 ([@bib50]). Potentially, the depletion of LIN-53 could facilitate reprograming by inhibiting PRC2, since the depletion of LIN-53 results in a global loss of H3K27me3 in the germline ([@bib50]). Considering the antagonistic relation between GLP-1^Notch^ and PRC2 on cell proliferation and gene regulation, we wondered whether GeCo triggered by the depletion of PRC2 would be sensitive to Notch signaling. Indeed, GeCo was strongly enhanced in PRC2-depleted (*mes-2*, *mes-3* or *mes-6* RNAi) animals, when they also carried the gain-of-function *glp-1(ar202)* allele ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---source data 1](#SD3-data){ref-type="supplementary-material"}). Moreover, similar to the LIN-53--depleted *gld-1(q497) gld-2(q485); glp-1(q175)* gonads ([Figure 1D](#fig1){ref-type="fig"}), the loss of GLP-1 effectively prevented GeCo in PRC2--depleted *gld-1(q497) gld-2(q485); glp-1(q175)* gonads ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---source data 1](#SD3-data){ref-type="supplementary-material"}). Together, these results suggest that GLP-1^Notch^ stimulates GeCo in PRC2-compromised gonads.10.7554/eLife.15477.014Figure 3.GLP-1^Notch^ enhances reprograming upon the depletion of PRC2.(**A**) Notch and PRC2 genetically interact in GeCo. Left: Fluorescent micrographs of *glp-1(ar202)* gain-of-function mutants expressing CHE-1--induced neuronal GFP. The animals were subjected to control RNAi or RNAi against PRC2 components (MES-2, 3, and 6), as indicated. Increased GLP-1^Notch^ signaling enhanced the GeCo+ phenotype upon PRC2 depletion. Control RNAi (mock) for each genetic background did not result in any GeCo (images not shown -- see quantification). Right: The corresponding quantifications. P-values were calculated using Student\'s t-test: p^1^=0,0006; p^2^\<0,0001; p^3^=0,0536; p^4^=0,0001; p^5^=0,4035; p^6^=0,0003. At least 200 animals were scored per condition. Error bars represent SEM. (**B**) GLP-1^Notch^ is required for GeCo in PRC2-depleted animals independently from proliferation. Left: Fluorescent micrographs of adults expressing CHE-1--induced nGFP, with the genotypes indicated above the panels. The animals were subjected to RNAi as indicated on the left. The first column shows heterozygous, the other two homozygous animals carrying the loss of function alleles *gld-1(q497)*, *gld-2(q485)* and, in the central panels, *glp-1(q175).* The animals were subjected to control RNAi or RNAi against PRC2 components (MES-2, 3, and 6). In the absence of GLP-1^Notch^, depletion of PRC2 components did not induce GeCo. Scale bars = 10 μm. Right: The corresponding quantifications. P-values were calculated using Student\'s t-test: p^1^\<0,0456; p^2^=0,0337; p^3^=0,0070; p^4^=0,0637; p^5^=0,0080; p^6^=0,1259. At least 70 animals were scored per condition. Error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.014](10.7554/eLife.15477.014)10.7554/eLife.15477.015Figure 3---source data 1.Quantification of GeCo upon PRC2 depletion.(**A**) Quantification of GeCo+ phenotype upon RNAi against PRC2 subunits in *glp-1(ar202)* mutants. (**B**) Quantification of GeCo in different genetic backgrounds with highly proliferative germlines upon RNAi against PRC2 subunits. More details can be found in the corresponding figure legends.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.015](10.7554/eLife.15477.015)

UTX-1 is required for GLP-1^Notch^-mediated GeCo enhancement {#s2-5}
------------------------------------------------------------

To determine how GLP-1^Notch^ might counteract PRC2, we depleted candidate Notch-activated genes ([Supplementary file 1](#SD5-data){ref-type="supplementary-material"}), and examined GeCo efficiency ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---source data 1](#SD4-data){ref-type="supplementary-material"}). The strongest suppression of the GeCo+ and GeCo phenotype was observed upon the depletion of *utx-1,* which also suppressed *mes-3* RNAi-mediated GeCo+ in *glp-1(ar202) *gonads ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Depletion of two other candidates, the uncharacterized C07G1.6 and the aldolase ortholog *aldo-1*, also suppressed GeCo+, albeit less efficiently ([Figure 4A](#fig4){ref-type="fig"}). Because UTX-1 was suggested to effect gonadal development by functioning in the somatic gonad ([@bib65]), we re-examined GeCo efficiency upon *utx-1* RNAi in the *rrf-1 (pk1417)* background. Importantly, in *rrf-1* mutants, RNAi is impaired in the somatic gonad, including the distal tip cell (DTC), which constitutes the germline stem cell niche ([@bib36]). Because the suppression of GeCo+ upon *utx-1* RNAi was observed also in the *rrf-1* background, UTX-1 does not seem to enhance GeCo by functioning in the somatic gonad ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Furthermore, different genetic backgrounds and RNAi agains *utx-1 *do not affect the expression levels of CHE-1 in the germline ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}).10.7554/eLife.15477.016Figure 4.The H3K27 demethylase UTX-1 is required for GeCo enhancement.(**A**) UTX-1 is critical for GeCo enhancement. Candidate Notch-activated genes, selected from [Supplementary file 2](#SD6-data){ref-type="supplementary-material"} with available RNAi clones, were assayed for a role in GeCo in *glp-1(ar202)* animals, expressing CHE-1--induced nGFP and treated with *lin-53* RNAi. While the additional depletion of *utx-1* had the strongest impact on GeCo+ and GeCo, the depletion of C07G1.6 and *aldo-1* had a weaker effect. Representative fluorescence micrographs are below the quantification chart. White dashed line outline the animal body, yellow lines outline gonadal areas with GeCo. P-values for GeCo+ were calculated using Student\'s t-test: p^1^=0,000013; p^2^=0,026; p^3^=0,021; p^4^\>0,1. At least 250 animals were scored per condition. Error bars represent SEM. nGFP = *gcy-5::gfp.* Scale bars = 10 μm. (**B**) As in A, but RNAi was performed against *jmjd-1.2* (H3K9/27me2 demethylase); *jmjd-3.1*, *jmjd-3.2*, and *jmjd-3.3*, (H3K27me2/3 demethylases); and *jmjd-2* (H3K9/36 demethylase). Only RNAi against *jmjd-1.2* suppresses GeCo+, though to a lesser degree compared to *utx-1* RNAi. Representative fluorescence micrographs are below the quantification chart. P-values for GeCo+ were calculated using Student\'s t-test: p^1^=0,0042; p^2^=0,035; p^3^\>0,2. At least 190 animals were scored per condition. Error bars represent SEM. Scale bars = 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.016](10.7554/eLife.15477.016)10.7554/eLife.15477.017Figure 4---source data 1.Quantification of GeCo upon double RNAi against *lin-53* and Notch-activated genes.(**A**) Quantification of GeCo+ upon RNAi against *lin-53* and Notch-activated genes. (**B**) Quantification of GeCo+ upon RNAi against *lin-53* and Histone demethylases. [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"} source data: Quantification of GeCo+ upon RNAi against *lin-53* and *utx-1* with and without *rrf-1* (*pk1417*) background. More details can be found in the corresponding figure legends.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.017](10.7554/eLife.15477.017)10.7554/eLife.15477.018Figure 4---figure supplement 1.UTX-1 is required for the GeCo+ enhancement upon the depletion of PRC2.(**A**) Adult *glp-1(ar202)* animals treated with *lin-53* or *mes-3* RNAi were additionally subjected to either control or *utx-1* RNAi. Depletion of *utx-1* strongly suppressed the GeCo+ phenotype. Suppression upon *utx-1* co-depletion with *lin-53* is also detectable in the *rrf-1(pk1417)* background which is permissive for RNAi in the germline but not in the somatic gonad and the DTC. Right: quantification: n = 715 were scored for *lin-53; utx-1* RNAi; n = 500 for *mes-3; utx-1* RNAi and n = 270 were scored for *lin-53; utx-1* RNAi in *rrf-1(pk1417)*. P-values were calculated using Student\'s t-test: p^1^=0,0588; p^2^=0,0042; p^3^=0,2454; p^4^=0,01713; p^5^=0,40479; p^6^=0,00271. Error bars represent SEM. (**B**) anti-HA antibody staining for the 3xHA-tagged CHE-1 protein, which is being induced after heat-shock treatment in the different genetic backgrounds: *glp-1(ar202); otIs305* (*hsp^prom^::che-1::3xHA*) *ntIs1* (*gcy-5^prom^::gfp*) treated with our without RNAi against *lin-53* and *utx-1*. As additional controls the strain *otIs305* (*hsp^prom^::che-1::3xHA*) *ntIs1* (*gcy-5^prom^::gfp*) with or without *lin-53* RNAi and heat shock treatment was used. No obvious changes in the induction of CHE-1::3xHA in the germlines of the different genetic backgrounds can be detected. Scale bars = 1 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.018](10.7554/eLife.15477.018)

Importantly, *utx-1* encodes a conserved H3K27me3 demethylase, an enzyme erasing the repressive mark deposited by PRC2 ([@bib1]; [@bib31]; [@bib45]), potentially explaining how its depletion impairs GeCo efficiency. However, a number of other H3K27me3 demethylases exist in *C. elegans,* which prompted us to test whether depletion of these demethylases might have an effect on GeCo in the *glp-1(ar202)* gonads. We RNAi-depleted *jmjd-1.2*, encoding a H3K9/27me2 demethylase ([@bib35]), *jmjd-3.1*, *jmjd-3.2*, and *jmjd-3.3*, which were reported to demethylate H3K27me2/3 ([@bib1]; [@bib35]; [@bib70]), and, as a control, *jmjd-2,* encoding a H3K9/36 demethylase ([@bib66]; [@bib22]) ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---source data 1](#SD4-data){ref-type="supplementary-material"}). Only the depletion of JMJD-1.2 suppressed GeCo+ significantly, though to a lesser degree than the depletion of UTX-1 ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---source data 1](#SD4-data){ref-type="supplementary-material"}). The suppression of GeCo by the depletion of UTX-1 or JMJD-1.2 stresses the importance of counteracting PRC2 in reprograming. However, only the expression of *utx-1* is activated by the GLP-1^Notch^ signaling, suggesting that it is the activity of UTX-1 which is key for the reprograming dependent on GLP-1^Notch^ signaling.

GLP-1^Notch^ and PRC2 regulate expression of the H3K27 demethylase UTX-1 {#s2-6}
------------------------------------------------------------------------

The inhibition of GeCo enhancement upon *utx-1* RNAi in the *rrf-1* background suggested that UTX-1 functions in the germline. To test the potential expression of *utx-1* in the germline, we constructed a strain expressing single copy-integrated, FLAG and GFP-tagged, functional UTX-1 (expressed from the endogenous *utx-1* promoter under the control of endogenous *utx-1* 3\'UTR). We found that this protein was indeed expressed in the germline ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). To examine the potential transcriptional regulation of *utx-1* expression by GLP-1^Notch^ and PRC2, we also created a strain expressing GFP-tagged histone H2B from the *utx-1* promoter (*putx-1* reporter), under the control of an unregulated (*tbb-2*) 3'UTR. This construct was also single-copy integrated into a defined genomic location. With both the UTX-1 fusion protein and the *putx-1* reporter, we expected expression patterns similar to that of other reported GLP-1^Notch^ target genes ([@bib38]; [@bib40]; [@bib33]). Among these, *lst-1* and *sygl-1* account for the role of GLP-1^Notch^ in stem cell maintenance, and both genes are expressed in the distal-most stem cells/progenitors ([@bib33]). By contrast, both the UTX-1 fusion protein and the *putx-1* reporter were little or not expressed in the distal-most, proliferative part of the germline ([Figure 5A--C](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Concomitantly with progression through meiosis, their expression increased toward the proximal end of the gonad ([Figure 5A--C](#fig5){ref-type="fig"}). When examining the existing mRNA hybridization patterns of Notch-activated and PRC2-repressed genes (33 genes), we noticed that half of these (18, all X-linked) are similarly expressed in the medial and/or proximal, but not the distal-most, gonads ([Supplementary file 2](#SD6-data){ref-type="supplementary-material"}), arguing against direct transcriptional activation of these genes by GLP-1^Notch^ in the wild type. Nevertheless, in agreement with the expression analyses, we observed increased expression of the *putx-1* reporter in PRC2-depleted gonads; this increase occurred throughout the gonad, including the distal-most region ([Figure 5A](#fig5){ref-type="fig"}). In situ hybridization for the endogenous *utx-1* transcript also showed increased expression throughout the gonad in the absence of PRC2 ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Moreover, expression of the *putx-1* reporter was higher upon increased GLP-1^Notch^ activity in *glp-1(ar202)* mutants, including the distal-most region where, in the wild type, *utx-1* is little or not expressed ([Figure 5B](#fig5){ref-type="fig"}). Importantly, we found that the activation of the *utx-1* promoter by Notch signaling was depended on the putative LAG-1/CSL binding sites within the promoter ([@bib67]), as deleting those sites reduced reporter expression by approximately one-fourth ([Figure 5C](#fig5){ref-type="fig"}). The interaction between LAG-1 and *utx-1* was also tested by chromatin immunoprecipitation (ChIP), performed on a strain expressing FLAG-tagged LAG-1 in either wild-type or *glp-1(ar202)* background ([Figure 5D](#fig5){ref-type="fig"} and [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}); the previously identified GLP-1^Notch^ targets, *lst-1* and *sygl-1* ([@bib33]), served as positive controls for the ChIP. Expectedly, we observed the enhanced binding of LAG-1 to the *utx-1* promoter, indicating that *utx-1* is a transcriptional target of GLP-1^Notch^ signaling. Summarizing, based on the observations in mutant backgrounds, PRC2 and GLP-1^Notch^ signaling have antagonistic effects on *utx-1* transcription. However, in wild type, the endogenous levels of GLP-1^Notch^ signaling are apparently insufficient to overcome PRC2-mediated repression of *utx-1* in the distal-most part of the gonad.10.7554/eLife.15477.019Figure 5.UTX-1 is regulated by GLP-1^Notch^ and PRC2.(**A--C**) Expression of *utx-1* is regulated by PRC2 and GLP-1^Notch^. Top: dissected gonads expressing a GFP reporter, driven from the *utx-1* promoter (*putx-1::GFP,* fused to histone 2B for nuclear localization to facilitate quantification), subjected to the indicated RNAi (**A**), crossed into the indicated genetic background (**B**) or carrying the indicated mutations in the reporter gene (**C**). a, b, and c indicate gonadal regions containing germ cells in mitosis (a), and leptotene/zygotene (b) or pachytene (c) stages of meiosis. Below: the corresponding GFP quantifications. The diagrams show GFP intensities relative to the control (indicated by green arrows) in regions a-c. Results are represented as average changes in the GFP intensity (relative to mock RNAi-ed or untreated animals). The error bars represent SEM. The numbers of analyzed gonads were as follows: n = 44 for wild-type reporter; n = 36 for *glp-1(ar202)*; n = 55 for wild-type reporter on control RNAi; n = 48 for *mes-2* (RNAi); n = 15 for *mes-3* (RNAi); n = 29 for *mes-6* (RNAi), and n = 20 for the LAG-1 binding sites deleted reporter. (**A**) The *putx-1::GFP* reporter is repressed by PRC2. In all *mes-depleted* gonads, the reporter was de-repressed in proliferating cells (a) as well as in more proximal gonadal regions (b-c). (**B**) The *putx-1::GFP* reporter is upregulated by GLP-1^Notch^. In the gain-of-function *glp-1(ar202)* mutant, the reporter was strongly derepressed in the proliferating cells in the distal-most gonad (a). Its expression was also increased in the more proximal regions (b-c), which, in this mutant background, contain proliferating cells instead of meiotic cells. (**C**) *putx-1::GFP* expression depends on the predicted LAG-1/CSL binding sites in the promoter. Upon deletion of putative LAG-1/CSL binding sites, the reporter expression was abolished. The changes in GFP intensities were highly significant (p-values were measured by independent t-tests) p^1^=4.85^--13^, p^2^=1.38^--20^, p^3^=1.18^--7^. (**D**) LAG-1 binds the *utx-1* promoter. Lysates of animals expressing FLAG-tagged LAG-1 (strain *wgIs591; lag-1::TY1::EGFP::3xFLAG*), either in wild-type or *glp-1(ar202)* background, were subjected to ChIP-qPCR analysis of the indicated genes. Negative controls and additional tested genes are shown in [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}. The qPCR amplicons were tested in at least three independent experiments. The results are shown as fold enrichment in anti-FLAG IP compared to IP with unspecific antibody. The 3'UTR of *lst-1* serves as a negative control. Interestingly, LAG-1 binding in the *glp-1(ar202)* gain-of-function background is stronger to the *utx-1* promoter than to the reported GLP-1^Notch^ targets *lst-1* and *sygl-1*. The asterisk indicates a p-value \< 0.05 (Students *t*-test). Error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.019](10.7554/eLife.15477.019)10.7554/eLife.15477.020Figure 5---figure supplement 1.The functional *utx-1* transgene is expressed in the same pattern as a GFP reporter coupled to the *utx-1* promoter.Shown is an adult with an outlined gonad. The full-length GFP-tagged functional UTX-1 (*rrrSi189)* is repressed in the distal, proliferative part. Nuclei entering meiosis and developing oocytes express the fusion protein progressively stronger. This expression pattern is identical with the pattern seen in the *utx-1* promoter reporter strains (*rrrSi185*, *rrrSi281*).**DOI:** [http://dx.doi.org/10.7554/eLife.15477.020](10.7554/eLife.15477.020)10.7554/eLife.15477.021Figure 5---figure supplement 2.The endogenous *utx-1* mRNA is upregulated in the absence of the PRC2-component MES-6.Shown are representative in-situ hybridisations against endogenous *utx-1* mRNA in dissected gonads. In M+Z- *mes-6(bn66)* mutants, *utx-1* is upregulated throughout the gonads compared to the control wild-type gonads. \'AS\' and \'S\' indicate antisense and sense probes.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.021](10.7554/eLife.15477.021)10.7554/eLife.15477.022Figure 5---figure supplement 3.Testing LAG-1 binding to additional genes by ChIP.Worm lysates (corresponding to 4 mg protein) of animals, with or without *lag-1::TY1::EGFP::3xFLAG* (*wgIs591*) transgene, were used for ChIP. Samples were incubated with 50 µl of FLAG ('specific' FLAG antibody) or HA antibodies ('unspecific' HA antibody) coupled to µMACS microbeads (Milteny). As negative control, lysate N2 or *glp-1(ar202)* worm lysates, which do not express the recombinant target protein, were used. Both negative control lysates did not show any differences during the ChIP experiment when tested with either specific antibody (anti-FLAG coupled to µMACS beads) or unspecific antibody (anti-HA coupled to µMACS beads). Lysates of worms expressing the recombinant target protein in N2 or *glp-1(ar202)* background were incubated with specific (anti-FLAG) and unspecific (anti-HA) antibodies coupled to µMACS beads. The qPCR amplicons were tested in a minimum of three independent ChIP-qPCR experiments. Quantification results are shown as fold enrichment of anti-FLAG µMACS™ beads using *wgIs591* lysate over anti-FLAG µMACS beads using lysate without *wgIs591* (*no lag-1::TY1::EGFP::3xFLAG*). Primer for qPCRs (sequence details above) were designed using Primer3Plus ([@bib64]). The FLAG-beads using lysates with *lag-1::TY1::EGFP::3xFLAG* show specific enrichment for tested target genes thereby validating the specificity of the ChIP. The asterisks indicates p-values \< 0.05 (Students *t*-test). Error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.15477.022](10.7554/eLife.15477.022)

Discussion {#s3}
==========

In the *C. elegans* germline, GLP-1^Notch^ signaling is essential for maintaining a pool of undifferentiated stem cells/progenitors. Here, we report an unexpected role of GLP-1^Notch^ signaling in promoting cell fate reprograming. To understand this phenomenon, we identified genes activated upon increased GLP-1^Notch^ signaling. While the identified genes include the physiological GLP-1^Notch^ targets, *sygl-1* and *lst-1*, many other genes, including *utx-1*, appear to be only weakly or not expressed in the distal-most region of the wild-type gonad, where both *sygl-1* and *lst-1* are induced by GLP-1^Notch ^([@bib33]). Thus, the wild-type levels of GLP-1^Notch^ signaling are either insufficient to induce expression of many potential target genes (see below), or their expression is controlled by additional mechanisms, perhaps similarly to *lip-1* mRNA, which, while induced by GLP-1^Notch^, is post-transcriptionally degraded in the distal-most gonad ([@bib23]; [@bib40]). In addition to its major proliferation-promoting function, GLP-1^Notch^ has been suggested to have a lesser role in promoting germ cell differentiation ([@bib25]). Some of the identified Notch-activated genes appear to promote germ cell differentiation, potentially explaining the proposed differentiation-promoting function of GLP-1^Notch^. However, whether these genes are activated by GLP-1^Notch^ and promote differentiation under physiological conditions remains to be determined.

Many of the Notch-activated genes are repressed by PRC2, suggesting that the expression of these genes is determined by the crosstalk between the extrinsic intercellular signaling pathway, Notch, and the intrinsic chromatin modifier PRC2. Indeed, at least in the case of *utx-1*, PRC2 appears to prevent its inappropriate expression in the distal-most gonad, which, nevertheless, can be overcome upon increased GLP-1^Notch^ signaling. Our findings suggest that GLP-1^Notch^ antagonizes PRC2, at least in part, by stimulating expression of the H3K27 demethylase UTX-1, which is essential for the enhancement of cellular reprograming. Previously, it was suggested that UTX-1 influences the germline by functioning in the somatic gonad ([@bib65]). However, by using the *rrf-1* background, which displays defective RNAi in the somatic gonad, including the DTC ([@bib36]), we found that the reprograming-promoting role of UTX-1 is unlikely to depend on its function in the somatic gonad. Although we cannot fully exclude the possibility that the reprograming-facilitating role of UTX-1 depends on its expression in another somatic tissue (such as the intestine, in which RNAi remains functional in the *rrf-1* mutant; [@bib36]), the germline expression of UTX-1 reported here suggests a germline-autonomous function. Consistent with this hypothesis, manipulating either PRC2 or GLP-1^Notch^ affected the germline expression of *utx-1*.

Although additional factors, such as the uncharacterized C07G1.6 and the ortholog of the human aldolase A ([@bib37]; [@bib57]) might contribute to reprograming, they appear to be less critical. In addition to UTX-1, another H3K27/H3K9-demethylating enzyme, JMJD-1.2 ([@bib35]), is required for enhanced reprograming. Similar to UTX-1, JMJD-1.2 is likely to be directly involved in regulating chromatin accessibility, since its depletion results in increased levels of the repressive H3K9me2 and H3K27me2 modifications ([@bib35]). The reprograming-promoting role of JMJD-1.2 might indicate that, besides further demethylation of H3K27me2, perhaps also the removal of H3K9me2 facilitates GeCo. Future studies will shed light on this interesting question.

UTX-1 orthologs in other species contribute to tissue-specific chromatin signatures, for example during myogenesis or in cardiac development ([@bib55]; [@bib41]), and have been implicated in germ-cell and somatic reprograming ([@bib44]). Together with our data, these findings underscore the importance of UTX-1 in cellular reprograming. Here, we suggest that one way the activity of UTX-1 may be stimulated to promote reprograming is through its Notch signaling-dependent transcriptional activation. Interestingly, an antagonistic relationship between Notch and PRC2 has also been observed in T-cell leukemia ([@bib48]). A fascinating possibility is that a regulatory principle described here could help explain the etiology of this and perhaps other human diseases linked to a pathological increase in Notch signaling.

Materials and methods {#s4}
=====================

Nematode culture and mutants {#s4-1}
----------------------------

Standard procedures were used to maintain animals. Worms (RRID:[WB_DL226](https://scicrunch.org/resolver/WB_DL226)) were grown at 25°C unless stated otherwise. All heat-shock and temperature-sensitive strains were kept at 15°C. The *C. elegans* lines used in this study are listed and described in detail in the [Supplementary file 3A](#SD7-data){ref-type="supplementary-material"}.

RNA interference experiments {#s4-2}
----------------------------

The enhancer-suppressor screen on Notch targets was performed by feeding the animals with bacteria containing RNAi clones from the Ahringer and Vidal RNAi libraries. The clones not present in either of these libraries were cloned using primers as described in detail in the [Supplementary file 3B](#SD7-data){ref-type="supplementary-material"}. Experiments were performed at 15°C, 20°C or 25°C using bleached embryos or overnight-synchronized L1 animals as stated in [Supplementary file 1](#SD5-data){ref-type="supplementary-material"}. The percentage of adult animals with the germline tumor phenotype was scored. To test germ-cell autonomy, RNAi clones that induced significant suppression or enhancement in either setting were re-tested in a strain carrying the *glp-1*(*ar202*) (RRID:[WB_GC833](https://scicrunch.org/resolver/WB_GC833)) allele and, additionally the *rrf-1*(*pk1417*) (RRID:[WB_NL2098](https://scicrunch.org/resolver/WB_NL2098)) mutation, which impairs RNAi primarily in the soma ([@bib58]). For this test, gravid adults were picked to RNAi plates and allowed to lay eggs overnight at the semi-permissive temperature of 20°C. Progeny was scored for enhancement or suppression of the germline tumorous phenotype at the young adult stage by DAPI staining of dissected gonads and scoring gonads as either wild-type, as containing a proximal or distal tumor but still some eggs, or as completely tumorous.

Reprograming experiments were carried out as F1-RNAi. Worms were put on RNAi plates and the following F1 generation was screened for phenotypes. Used RNAi clones are described in the [Supplementary file 3B](#SD7-data){ref-type="supplementary-material"}. The genotype of the worms used for germ cell reprograming assays is BAT28 (*otIs305 ntIs1,* RRID:[WB_OH9846](https://scicrunch.org/resolver/WB_OH9846), details in Supplemental Materials and methods). Animals were synchronized by bleaching and eggs were put on NGM-agar containing *E. coli* OP50 (RRID:[WB_OP50](https://scicrunch.org/resolver/WB_OP50)) as a food source to grow at 15°C until worms reached the L4-stage. At this stage 15--20 worms were put per well of a 6-well plate, containing bacteria expressing dsRNA or carrying an empty RNAi vector, and grown at 15°C until most of the F1 progeny reached the L3/L4 stage. The plates were heat-shocked at 37°C for 30 min followed by an overnight incubation at 25°C. Next day (\~16 hrs post heat-shock) the plates were screened for progeny showing ectopic GFP induction in the germline. To induce the Glp phenotype in *glp-1(ar202)*, the animals were shifted to room temperature 9 hrs before the heat-shock. For double RNAi, bacteria were grown as saturated culture. The OD~600~ was measured to ensure that the bacteria were mixed in an appropriate 1:1 ratio and subsequently seeded on RNAi 6-well plates. The RNAi screen was performed as described above. The p-values were calculated using Student\'s *t*-test.

Cell cycle arrest by HU treatment and EdU staining {#s4-3}
--------------------------------------------------

Hydroxyurea (HU) treatment was carried out as previously described ([@bib15]; [@bib50]). HU was added to seeded RNAi-plates at a final concentration of 250 µM. L4 worms (strain BAT32, details in [Supplementary file 3A](#SD7-data){ref-type="supplementary-material"}) grown on RNAi-plates were transferred to HU plates and incubated at room temperature for 5 hrs prior to heat-shock in order to induce CHE-1 expression. To test HU efficiency, control animals were treated with HU for 12 hrs with subsequent staining for DAPI and H3Ser10ph (pH3) antibody (Abcam \#ab5176). After overnight incubation, the worms were assessed for GFP induction in the germline as described above. To assess the efficiency of the HU treatment, the *E. coli* strain MG1693 (*E. coli* stock center), with incorporated 5-ethynyl-20-deoxyuridine (EdU), was used to feed L3/L4 worms. EdU in combination with DAPI staining was performed similar to the procedure described previously ([@bib29]) and according to the manufacturer\'s instructions (Invitrogen, Europe) of the EdU labeling kit. The Click-iT EdU reaction buffer (Invitrogen, Europe) was mixed with Alexa Fluor azide ('click' reaction) dye to detect cells that were replicating DNA. Staining was performed by freeze cracking worms after fixation with 2% formaldehyde.

*C. elegans* tiling array analysis {#s4-4}
----------------------------------

Parental animals were raised at 15°C and shifted to 25°C for egg laying. Offspring was dissected after the L4-adult transition. Fifty gonads per analyzed genotype in triplicates were dissected in M9 containing levamisole. RNA was isolated using the PicoPure RNA Isolation Kit (Applied Biosystems) according to the manufacturer's recommendations. Total RNA (200 ng for the Notch ON/OFF experiments or 100 ng for the *mes*/wild-type experiments) was amplified using the Affymetrix GeneChip WT Amplified Double Stranded cDNA Synthesis Kit according to the manufacturer's instructions. The Affymetrix GeneChip WT Double-Stranded cDNA Terminal Labeling Kit was used for the fragmentation and labeling of 7.5 μg cDNA. The labeled material was loaded onto Affymetrix GeneChip C. elegans Tiling 1.0R Arrays and hybridized at 65ºC for 16 hrs. The arrays were washed in an Affymetrix Fluidics station with the protocol FS450_0001 and scanned in an Affymetrix GeneChip Scanner 3000 with autoloader using Affymetrix GCC Scan Control v. 3.0.0.1214 software. All tiling arrays were processed in R (32,33) using Bioconductor (34) and the packages tilingArray and preprocessCore. The arrays were RMA background corrected and log2 transformed on the oligo level using the following command:

expr \<- log2 (rma.background.correct (exprs (readCel2eSet (filenames,rotated = TRUE)))).

We mapped the oligos from the tiling array (bpmap file from [www.affymetrix.com](http://www.affymetrix.com)) to the *C.elegans* genome assembly ce6 ([www.genome.ucsc.edu](http://www.genome.ucsc.edu)) using bowtie ([@bib39]), allowing no error and unique mapping position. Expressions for individual transcripts were calculated by intersecting the genomic positions of the oligos with transcript annotation (WormBase WS190) and averaging the intensity of the respective oligos. For the *mes-4*/wt experiment, no quantile normalization was performed as the distributions for the *mes-4* mutant and the wt differed substantially. In the case of the Notch ON/OFF dataset quantile normalization was performed on the level of transcripts. The p-values were calculated in R with the hypergeometric distribution function \'phyper\'.

Validation of array analysis by RT-qPCR {#s4-5}
---------------------------------------

RNA was isolated as described above. cDNA was synthesized with oligo dT primer using the ImProm II Reverse Transcription System from Promega according to the manufacturer's instructions. cDNA was used for qPCR with the Absolute QPCR SYBR Green ROX Mix (AbGene) on an ABI PRISM 7700 system (Applied Biosystems). qPCR reactions were performed as described previously ([@bib7]). At least one primer in each pair is specific for an exon-exon junction. Sequences of the used primers are described in detail in the [Supplementary file 3C](#SD7-data){ref-type="supplementary-material"}. Mouse RNA was added before RNA isolation and reverse transcription, allowing for normalization to *cyt-c* and thereby correcting for variations in RNA isolation and reverse transcription. Standard curves for quantification were generated from a serial dilution of input cDNA for each primer pair. The amount of target present in each replicate was derived from the standard curve; an average was calculated for each of the triplicates. To compare total mRNA levels, the qPCR results were normalized to mouse *cyt-c* and to the *C. elegans* tubulin gene *tbb-2*, and fold enrichments were calculated.

In situ hybridization for *utx-1* {#s4-6}
---------------------------------

RNA in situ hybridization was performed and analyzed as previously described ([@bib7]). Description of the primer pairs to generate probes from cDNA can be found in the [Supplementary file 3C](#SD7-data){ref-type="supplementary-material"}. Images were captured with a Zeiss AxioImager Z1 microscope, equipped with a Zeiss AxioCam MRc camera. Images were taken in linear mode of the Axiovision software (Zeiss) and processed with Adobe Photoshop CS4 in an identical manner.

Chromatin immunoprecipitation and qPCR (ChIP-qPCR) {#s4-7}
--------------------------------------------------

ChIP was performed as described ([@bib4]). In brief, worms (strains OP591, RRID:[WB_OP591](https://scicrunch.org/resolver/WB_OP591), and BAT890) were washed with M9 buffer and frozen as 'worm popcorn' in liquid nitrogen prior to pulverization with a mortar and pestle. The powder was dissolved in 10 volumes of 1,1% formaldehyde in PBS + 1 mM PMSF and incubated 10 mins with gentle rocking at room temperature with subsequent quenching for 5 mins at room temperature by adding 2,5 molar glycine (final concentration 125 mM). After centrifugation with 4.000 g at 4°C the pellet was washed with ice-cold PBS+1 mM PMSF and resuspended in 50 mM FA buffer (50 mM HEPES/KOH pH 7,5; 1 mM EDTA; 1% Triton-X 100; 0,1% sodium deoxycholate; 150 mM NaCl) + 1% sarkosyl + protease-inhibitors. Samples were sonicated twice using the Biorupter (15 times 30 s ON, 30 s OFF) on high settings at 4°C followed by spinning at 13.000 g, 15 min, 4°C. The supernatant corresponding to 4 mg of protein measured by Bradford assay was used for ChIPs. Samples were incubated with 50 µl of FLAG or HA antibodies coupled to µMACS microbeads (Milteny) (all blocked with 5% milk in FA-buffer). After incubating 1 hr at 4°C, the beads where washed in µMACS matrix columns in a magnetic rack with FA buffer containing 1 M and 0.5 M NaCl and subsequent wash with TE and TEL buffer (0,25 M LiCl; 1% Sodium deoxycholate; 1 mM EDTA; 10 mM Tris pH 8,0). Bound material was eluted with 65°C pre-warmed 125 µl ChIP elution buffer (1% SDS, 250 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA) and fixation was reversed using 2 µl of 10 mg/ml Proteinase K at at 50°C for 1 hr followed by 65°C incubation overnight. DNA was purified using the Quiaquick PCR purification kit in a final volume of 40 µl and 1 µl was used for qPCR. Negative controls were used to assess the quality of the ChIP and fold enrichment of the target genes: lysates (N2 worms) which do not express the recombinant target protein with specific antibody (anti-FLAG coupled to µMACS beads) and lysates of worms expressing the recombinant target protein with unspecific antibody (anti-HA coupled to µMACS beads) controls, respectively. Primer for qPCRs was designed using Primer3Plus ([@bib64]) with the following settings: amplified region min. 100 bp -- max. 200 bp; GC content: 50--60%; min. primer length: 18 nt -- max. length 24 nt; melting temperature: min. 58°C -- max. 63°C; max.; 3\' self complementary allowance set to 1; max. allowed length of a mononucleotide repeat (max. poly-x): 3. Sequences of the used primers are listed in in the [Supplementary file 3C](#SD7-data){ref-type="supplementary-material"}. The qPCRs were run on CFX96 Touch Real-Time PCR Detection System from BioRad using the Maxima SYBR Green/ROX qPCR Master Mix (2X). The data analysis was performed by calculating the ΔΔCt-values. Differences were assessed using Student\'s *t*-test.

DAPI staining and counting of germ cells {#s4-8}
----------------------------------------

Worms were transferred to a slide and fixed by adding 10--20 µl 95% ethanol and letting evaporate the ethanol. The ethanol fixation was repeated 2 more times before adding the DAPI solution in microscopy mounting media (vectashield from Vector or similar). The samples were sealed with a coverslip and nail polish before microscopy. Fluorescent micrographs were recorded with Zeiss AxioImager Z1 microscope and the SensicamII camera (PCO) and the micromanager software was used to capture Z-stack images with 0.5 µm slice steps. Images subject to direct comparison were taken at identical exposure times. Counting of germ cells within the range from the DTC to the turn of gonadal arms of *glp-1(ar202); hsp::che-1; gcy-5::gfp* animals treated with either mock or *lin-53* RNAi was performed using the Z-stacks. Micromanager was used to control the Z-stack levels and the ImageJ plugin for cell counting for scoring the number of germ cells. Germ cell counts in gonads of Notch ON: *gld-2(q497) gld-1(q485); glp-1(ar202)* and Notch OFF: *gld-2(a497) gld-1(q485); glp-1(e2144)* ([Figure 1---figure supplement 2](#fig1s1){ref-type="fig"}) and germline tumor phenotype in *glp-1(ar202)* and *glp-1(ar202); rrf-1(pk1417)* were scored after dissection, formaldehyde fixation and DAPI staining. For Notch ON and Notch OFF mutants, the central plane of the gonads was imaged and germ cells in the entire dissected gonad were counted using the CellCounter plugin with ImageJ. For each of the two strains, germ cells in the entire gonad of 15 dissected gonads were counted.

Immunostaining and antibodies {#s4-9}
-----------------------------

Antibody stainings of intact worms were performed using a freeze-crack procedure as described ([@bib12]). In brief, after washing, worms were resuspended in 0.025% glutaraldehyde, and frozen between two frost-resistant glass slides on dry ice. Separating the glass slides while frozen creates additional cracks in the cuticle. Acetone/methanol or 4% paraformaldehyde in 0.1 M phosphate buffer for 1 hr on ice fixation was used. Worms were washed off the slides in PBS, blocked with 0.2% gelatin + 0.25% Triton in PBS, and stained. Primary antibodies were diluted in PBS with 0.1% gelatin and 0.25% Triton and fixed worms were incubated 4 hrs - overnight at 4°C. After PBS washes secondary antibody was applied for 3 hrs. After PBS washes worms were mounted with DAPI-containing mounting medium (Dianova, \#CR-38448) on glass slides. The primary antibodies used were anti-H3K27me3 (1:400; gift from Dr. Hiroshi Kimura); anti-HA (1:100, Roche \#12CA5; acetone fixation); anti-H3Ser10ph (1:400, Abcam, \#ab14955; acetone fixation). Secondary antibodies were Alexa Fluor dyes applied at 1:1000 dilution.

Stainings for H3K27me3 on dissected gonads were performed using anti-H3K27me3 from Millipore (catalogue number 07--449, Lot 1959680; courtesy of Jan Padeken, Gasser laboratory) on dissected gonads. The adult animals were dissected in M9 containing levamisole, fixed with 2% paraformaldehyde in PBS on poly-lysine coated slides, snap-frozen on dry ice, freeze-cracked, incubated for 5 mins in ice-cold DMF at −20°, washed for 5 mins in PBS 0.1% Tween-20 at room temperature, blocked for 20 mins in PBS 0.1% Tween-20 + 5% BSA and incubated with the primary antibody over night at 4°C. Secondary antibodies (Alexa 488, goat anti rabbit, 1:500) were applied for 2 hrs at room temperature. Slides were then washed three times for 5 mins in PBS 0.1% Tween-20 at room temperature and mounted with Vectashield mounting medium containing DAPI.

Transgenic animals and reporter GFP quantifications {#s4-10}
---------------------------------------------------

The transcriptional reporter gene *putx-1::gfp-h2b (rrrSi185)* was constructed from the 1302 bp putative promoter region of the gene *utx-1* (*human UTX (Ubiquitously transcribed TPR on X) homolog - 1*) fused to sequences encoding for GFP-H2B and the ubiquitously expressed *tbb-2* 3'UTR using the Gateway Reporter Cloning System ([@bib46]). The reporter gene *putx-1::gfp-h2b (rrrSi185* and *rrrSi281)* was constructed with the following primers:

putx-attB4: GGGGACAACTTTGTATAGAAAAGTTGGGATTTTATCTTCATCGGACCTG

putx-attB1 : GGGGACTGCTTTTTTGTACAAACTTGTGGCGGTGTGAGAAGCGATAC

The full-length functional transgene *putx-1::flag-gfp-utx-1::utx-1 3'UTR (rrrSi189)* was constructed with the following primers: utx-1+3UTR+attB2 L

ggggacagctttcttgtacaaagtggACGACGAATCAGAACCTCTGCCGGAGGAGCGTCATgtaag

utx-1+3UTR+attB3 R ggggacaactttgtataataaagttgaatgcggatactgccttctc

The functional UTX-1 transgene *putx-1::flag-gfp-tev::utx-1::utx-1 3'utr(rrrSi189)* contains the same promoter as the transcriptional reporter, the full-length *utx-1* genomic sequence as well as the endogenous 3'UTR, and was equipped with N-terminal GFP, FLAG, and TEV tags. Transgenic animals were produced as single-copy integrants using the MosSCI direct insertion protocol ([@bib16]). The *rrrSi189* transgene is functional, as it rescues the *utx-1* mutant (*ok3553* allele). For GFP quantification, gonads were dissected from live animals in M9 buffer containing levamisole and mounted to glass microscopy slides ([@bib16]). Fluorescent micrographs were recorded with Zeiss AxioImager Z1 microscope and a Zeiss Axioncam MRm REV 2 CCD camera was used to capture images. Fluorescence intensities were quantified using ImageJ. GFP intensities were normalized to the picture background and corrected with the average autofluorescences measured in wild type (N2) gonads at the corresponding temperatures. Images subject to direct comparison were taken at identical exposure times and were processed with Adobe Photoshop CS4 in an identical manner. The numbers of analyzed gonads were as follows: n = 44 for wild-type reporter; n = 36 for *glp-1(gf ^ts^)*; n = 55 for wild-type reporter on control RNAi; n = 48 for *mes-2(RNAi)*; n = 15 for *mes-3(RNAi)*; n = 29 for *mes-6(RNAi)*, and n = 20 for LAG-1 binding sites deleted reporter.

Genetic interaction of *glp-1* and *mes-2* {#s4-11}
------------------------------------------

Alleles used were *glp-1(ar202)* and *mes-2(bn11)*. Worms were grown at the semi-permissive temperature of 20°C and gonads were dissected and DAPI-stained shortly after the L4-young adult transition.

The experiment was performed twice. In a first round, a low number of gonads were examined to identify whether the double mutant had a phenotype and to define phenotypic categories to score. Based on the observation of a clear and penetrant phenotype, gonads were scored in a second round according to the categories defined in the first round.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Notch signaling antagonizes PRC2-mediated silencing to promote reprograming of germ cells into neurons\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Julie Ahringer as the Reviewing Editor and Kevin Struhl as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this study the authors investigate the reprogramming of germ cells into neurons in the adult *C. elegans* germ line upon removal of certain chromatin modifiers, an in vivo reprogramming process they refer to as GeCo. Here they show a requirement for Notch signalling in this process, and suggest that this role of Notch is independent of its role in promoting proliferation. They also identify targets of Notch, one of which is an H3K27 demethylase, UTX-1, suggesting a mechanism by which Notch-directed transcription may counteract PRC2-dependent repression.

Essential revisions:

1\) The claim that the antagonism between GLP-1 Notch signaling and PRC2 that you study here is functionally relevant in the germline, or conceptually, in reprogramming, is not substantiated. In particular, the X-linked GLP-1 transcriptional targets you studied (e.g., *utx-1*) do not appear to be GLP-1 transcriptional targets in normal germline development, although they may become GLP-1 targets in the absence of PRC2. The data seem consistent with GLP-1 signaling acting within an abnormal permissive context generated by loss of PRC2. The paper should be reframed to address this point or the claim should be justified.

2\) The authors assume that genetic perturbations employed are germline autonomous, but do not experimentally demonstrate that this is the case. The *mes* genes function in the soma (Ross and Zarkower, 2003). It has also been shown that loss of gene activity in the somatic gonad can result in enhancement of the *glp-1(ar202*) tumorous germline phenotype (McGovern et al., 2009). Therefore, the authors should show that the *mes* gene mutant enhancement of *glp-1(ar202)* is germ cell autonomous, which is required based on the mechanism proposed. Similarly, the authors use RNAi of Notch upregulated genes to substantiate the argument that the genes are relevant for germ cell proliferation. While data from others has shown that some of the identified genes function in the germline (for example, Kershner et al., 2014; Doyle et al., 2000) it is also well known that loss of function of genes that function only in the soma can result in reduced proliferation (for example, Dalfo et al., 2012). Note that for *utx-1*, its function in reprogramming is interesting whether it acts in the germline or the soma, although models for its action would be different.

3\) The authors conclude that the GeCo phenotype requires Notch signaling, independent of proliferation. To be confident in the conclusion, the following issues should be addressed.

A\) As *lag-1* is the transcriptional effector of Notch signaling in *C. elegans*, [Figure 1C](#fig1){ref-type="fig"} does not give confidence that the *lag-1* RNAi is working as the *lag-1* RNAi should cause the *glp-1* gain of function germ cells to enter meiosis, resulting in fewer germ cells and a different germline morphology compared to the mock treated (Berry et al., 1997).

B\) From the images in [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, it appears that the HU treatment may have not been effective. HU should inhibit mitosis in the germ line, leading to fewer germ cell nuclei, and it should induce cell cycle arrest, leading enlarged germ nuclei. Although the HU image in [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} shows a lack of Edu positive nuclei, there is no evidence of enlarged germ cell nuclei or of reduced germ cell number, which is expected for HU treatment (see [Figure 4](#fig4){ref-type="fig"} in Gartner et al., 2004). The control for HU treatment is also not adequately explained.

C\) What developmental or cell cycle state are the germ cells with more or less Notch activity? This is important since Notch regulates the proliferative state of germ cells. Cells that are pre-meiotic may not be able to convert readily compared to proliferative germ cells. Note that this is independent of cell numbers, but relies on markers and morphology of the germ line. Conversely, in the HU block experiment, do the germ cells enter the meiosis pathway?

D\) Although they should be related, the assessment of total germ cell number is not a measure of mitotic germ cell number, which is the key measure of proliferation. To determine whether the increase in conversion is a consequence of an increase in number of mitotic germ cells, the authors should quantify the number of mitotic germ cells (e.g., using phospho histone H3 staining) rather than total germ cell number.

4\) It would improve the paper to show a stain of H3K27me3 in the different cellular environments (Notch single and triple mutants) and to compare the location of H3K27me3 with locations that can respond to heterologous regulators.

5\) H3K27me3 might be predicted to silence transgenes introduced into worms, such as those involved in reprogramming. The authors should check the level of CHE-1 expression in the different cellular environments to make sure that the changes they track reflect the response of the tissue and not the expression of the inducer.

6\) The authors should improve the citations for previous *C. elegans* studies on Notch, PRC2, and reprogramming in *C. elegans* (e.g. from the Mango, Rothman, Krause, Priess labs such as Djabrayan et al., Genes & Development, 2012, Yuzyuk et al., Dev Cell, 2009).

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Increasing Notch signaling antagonizes PRC2-mediated silencing to promote reprograming of germ cells into neurons\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Kevin Struhl (Senior editor), a Reviewing editor, and three reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below. Two are particularly important:

1\) Your new experiments do not convincingly show that the interaction between Notch and PRC2 is germ line autonomous, so it remains uncertain where PRC2 and *utx-1* are acting in *glp-1(ar202)* proliferation and conversion into neurons. Gene activity in the soma can modify *glp-1(ar202)* overproliferation in the germline.

2\) Second, the conclusion that UTX-1 is a germ line target of Notch is not convincing.

These and the other points raised in the attached reviews all need to be addressed, either by experiments or by changing your text. Please note that we can offer no further opportunities for additional work or modification thus the binding decision must be made on your next revised submission.

Additionally, points in your paper overstated or incorrect as described in the reviews. For example, Vandamme et al. 2012 did not show endogenous UTX-1 expression in the germ line, contrary to what is stated in your paper. In other places there is insufficient information provided to allow readers outside of the immediate field to understand what is already known and what then is an expected result.

*Reviewer \#1:*

The investigation of the cell cycle vs Notch effects is carefully done and convincing.

The question of cell autonomy is not convincing ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"} and [Figure 5](#fig5){ref-type="fig"}). In particular:

The authors use *rrf-1* to address whether genes function within the germ line. The logic is that a germline autonomous regulator should not be perturbed by the addition of an *rrf-1* mutation. This is a weak line of reasoning as *rrf-1* is required in some somatic tissues but not others: See Kumsta and Hansen 2012.

In addition, mes-2 looks affected by *rrf-1* mutations. So is this actually a germ-line role of PRC2? Or could it be somatic? And why do *mes-3* and *mes-6* look different from *mes-2*?

*rrf-1* appears to modify the tumorous phenotype on its own. Why do *rrf-1* mutants suppress *glp-1* Tumors?

Finally, it is unclear how the authors are calling the cut off for germline autonomous vs. somatic effects. Not only for *mes-2* but for all genes.

A simpler way to address this question would be to express a rescuing construct in the germ line alone. E.g. a mini Mos construct. This is most critical for *utx-1*, in my opinion.

The conclusion that UTX-1 acts in the germ line is also not convincing for three reasons.

First, Seelk et al. use the promoter of *utx-1* with a histone GFP readout ([Figure 5](#fig5){ref-type="fig"}). While this shows changes in *glp* and *mes* mutants, it is convincing with regard to UTX activity because the germ line relies heavily on post-transcriptional regulation. To ensure that the protein reflects RNA levels, the authors need to look at the endogenous protein or a single copy, rescuing reporter that has the whole protein and regulatory sequences.

Second, Vandamme 2012 argued that UTX-1 activity in the soma influenced the germ line, perhaps through the distal tip cell. The distal tip cell signals through the Notch pathway, so this is a reasonable idea.

Third, Vandamme 2012 did not show endogenous UTX-1 expression in the germ line, as stated by Seelk et al.

The key question is whether UTX and H3K27me3 function in the germ line and downstream of Notch to control reprogramming via target gene regulation. It may be that some events occur in the soma, so I don\'t think the authors need to test everything for cell autonomy, but *utx-1* would be useful, particularly given previous publications suggesting at distal tip cell focus.

The H3K27me3 stains appear to have been done without controls, so it is impossible to judge if there are any changes in different strain backgrounds. (If there were, it would be more convincing that *utx* was acting in the germ line.) A well-controlled experiment would include an on-slide control (e.g. a marked N2) and a germline control (e.g. histone H3). The ratio of H3K27me3:H3 would give an indication of whether levels are changing.

References to be added:

Introduction, second paragraph: add Horner et al., 1998 as one of the first examples of reprogramming in an intact organism and of timing of competence.

Introduction, second or third paragraph: add Yuzyuk 2009 for PRC2 -dependent termination of plasticity and promotion of cell fate stabilization.

Introduction, third paragraph: add Maures 2011, Jin 2011, maybe Vandamme 2012 for identification of utx-1 as a regulator of H3K27me3.

*Reviewer \#2:*

A number of changes need to be made to the manuscript so that the results and possible conclusion are more transparent.

1\) Paragraph with heading "Both GLP-1^Notch^ and PRC2 regulate expression of the H3K27 demethylase UTX-1":

A\) The authors should first explain what is the expected expression pattern for a GLP-1 transcriptional target, based on the known and experimentally validated direct transcriptional targets of GLP-1 Notch in the gonad, *lst-1* and *sygl-1*, described in Kershner et al. 2015. The failure to do so makes the paper hard to understand for readers outside the immediate *C. elegans* field.

B\) The expected pattern based on the work of Kershner et al., 2015, is that GLP-1 dependent transcripts are limited to the distal most 5 to 10 cell diameters, consistent with ligand expression limited to the distal tip cell. The authors interpretation of the *putx-1::gfp* ([Figure 1A](#fig1){ref-type="fig"}) and *putx-1::FLAG-GFP::utx-1* ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) is that there is weak expression in the distal-most region of the germline where GLP-1 targets are expected to be expressed. However, this reviewer cannot see any *putx-1* GFP signal above background, and this view is supported by the absence of mRNA in the distal-most germline from the in situ hybridization experiments in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Therefore, the sentence \"Consistent with the expression patterns of the endogenous *utx-1* (Vandamme et al. 2012) and of a GFP used, functional *utx-1* transgene ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), the *utx-1* reporter was weakly expressed in the distal-most, proliferative part of the germline ([Figure 5A-C](#fig5){ref-type="fig"}).\" should be changed to indicate that there is \"little or no expression in the distal-most, proliferative part of the germline\".

C\) The sentence \"However, a similar expression pattern has been reported for another reported GLP-1Notch target gene, *lip-1* (Hajnal and Berset 2002; Lee et al. 2006).\" should be removed. Hajnal and Berset 2002 showed that *lip-1* is a *lin-12* transcriptional target in vulval development, with no information on *glp-1* or the germline. Lee et al. 2006 did not perform the *glp-1* dependence experiment comparing *gld-1 gld-2* with *gld-1 gld-2; glp-1*, which the authors in this manuscript performed, and thus it is uncertain if *lip-1* is a germline target of GLP-1 in distal-most germ cells.

D\) In the first two paragraphs of the subsection "UTX-1 is required for GLP-1^Notch^-mediated GeCo enhancement". There is no evidence that GLP-1 signaling occurs in the medial/proximal gonad, as GLP-1 protein is not found in this region (Crittenden et al., 1994). Therefore, the expression of the 33 genes indicated is either an indirect consequence of GLP-1 signaling (another transcription factor that is transcribed in the distal-most germline stem cells in response to GLP-1 signaling which then acts to induce transcription much later in development, in pachytene cells) or is not regulated by GLP-1 signaling at all. The sentence needs to be changed to indicate that the observed expression is *not* consistent with direct GLP-1 transcriptional regulation.

2\) In the subsection "Both GLP-1^Notch^ and PRC2 regulate expression of the H3K27 demethylase UTX-1". \"Deleting those sites drastically reduced reporter expression in the medial and proximal portions of the gonad ([Figure 5C](#fig5){ref-type="fig"}).\" [Figure 5C](#fig5){ref-type="fig"} indicates that the decrease is at most 25%. The sentence should be \"Deleting those sites reduced reporter expression by approximately 25% in the medial and proximal portions of the gonad ([Figure 5C](#fig5){ref-type="fig"}).\"

3\) The last paragraph of the subsection "Both GLP-1^Notch^ and PRC2 regulate expression of the H3K27 demethylase UTX-1".

\"Overall, our observations suggest that PRC2 and GLP-1^Notch^ signaling have antagonistic effects on *utx-1* transcription. However, the endogenous levels of GLP-1^Notch^ signaling are apparently insufficient to overcome PRC2-mediated repression in the distal part of the gonad\" does not emphasize the findings in the manuscript and should be rewritten in the following way:

\"Overall, our observations suggest that PRC2 and GLP-1^Notch^ signaling have antagonistic effects on *utx-1* transcription that can be observed in a PRC2 mutant background. However, in wild type the endogenous levels of GLP-1^Notch^ signaling are apparently insufficient to overcome PRC2-mediated repression in the distal part of the gonad\".

4\) Discussion. While the sentence \"This suggests that the identified set of genes may contain additional physiological GLP-1Notch targets.\" may be true, of the genes analyzed in this manuscript, none have been shown to be convincing GLP-1^Notch^ targets in wild type animals.

The Discussion should instead focus on their novel findings -- that PRC2 is apparently acting antagonistically to prevent certain GLP-1^Notch^ targets from being expressed in the germline, which makes sense as it is likely important to block the expression of some somatic GLP-1 targets from being expressed in germ cells, and that these include *utx-1* which promotes reprogramming.

*Reviewer \#3:*

I think in general the study stands up as providing evidence that there is some antagonism between Notch activation and PRC2-mediated repression of genes, and that enhancement of Notch activity in germ cells yields similar transcriptional consequences to loss of PRC2 repression in germ cells -- enhanced X-linked gene expression. Similarly, these conditions also both make it easier to drive germ cells towards somatic differentiation upon ectopic activation of somatic fate drivers, such as *che-1*.

The question still stands whether this is informative for either normal germ cell development or for understanding the balance of activation and repression controlling early embryo development or programming/reprogramming.

I think it\'s clear that the processes studied are artificial in terms of germ cell development -- but not entirely so. I think the authors do show that the balance of Glp-1 signaling and PRC2 repression are essential for normal germ cell development. I also think they\'ve shown they can uncouple some of the Glp-1-dependent effects from proliferation phenotypes. This probably underlies the differences in absolute phenotypes between Glp-1 gof and PRC2 mutants (which are presumably maternally rescued mutants): proliferation defects in the former compared to little visible defects in the maternally rescued germ cells. It\'s formally interesting that raising the level of Notch activity has the same effect on transcriptional regulation as lowering PRC2 activity in these cells. It\'s interesting that this seems to be separate from any need for proliferation to be dysregulated.

I think the authors have adequately addressed the technical concerns about this conclusion.

There still is a bit of what I view as semantic issues with how some things are phrased that can be over-interpreted by the reader, or may indeed still be overstatements by the authors:

For example, the subsection "GLP-1^Notch^ and PRC2 have antagonistic functions in the germline" states \"that, in the *C. elegans* gonad, specific PRC2-repressed genes are activated via GLP-1^Notch^ signaling.\" This certainly implies that *glp-1* activation of genes like *utx-1* is part of normal germ cell function, which is unlikely to be true.

Lastly, the description of the *mes* mutants used needs to be clarified. I am assuming that when the authors are referring to *mes-2(bn11)* mutants, etc. they are actually referring to the F1 maternally rescued homozygote offspring (e.g., M Z ). It is important to clarify that these animals and their germ cells are not completely devoid of a history of PRC2 activity, which is why they have germ cells to count and look at in the first place. Absent maternal MES protein, there wouldn\'t be but a few dying germ cells in the adult gonads to look at.

10.7554/eLife.15477.027

Author response

*Essential revisions:*

*1) The claim that the antagonism between GLP-1 Notch signaling and PRC2 that you study here is functionally relevant in the germline, or conceptually, in reprogramming, is not substantiated. In particular, the X-linked GLP-1 transcriptional targets you studied (e.g., utx-1) do not appear to be GLP-1 transcriptional targets in normal germline development, although they may become GLP-1 targets in the absence of PRC2. The data seem consistent with GLP-1 signaling acting within an abnormal permissive context generated by loss of PRC2. The paper should be reframed to address this point or the claim should be justified.*

We would like to point out that, despite using compound mutants to uncover putative GLP-1 targets, these strains contain wild-type PRC2. Thus, *utx-1*, along with at least some other identified genes, such as the confirmed targets *sygl-1* and *lst-1* (Kershner et al. 2014), is regulated in the context of normal PRC2. In agreement with GLP-1-- dependent regulation of *utx-1* in normal development, *utx-1* is bound by LAG-1 and the deletions of LAG-1 binding sites in the *utx-1* promoter, expressed in the wild-type background, impair its expression.

It is true, however, that whether normal levels of Notch signaling are sufficient to antagonize PRC2 repression in normal development remains uncertain. We made this point clear at the end of the Results section, stating: "However the endogenous levels of GLP-1/Notch signaling are apparently insufficient to overcome PRC2-mediated repression (of *utx-1*) in the distal part of the gonad."

*2) The authors assume that genetic perturbations employed are germline autonomous, but do not experimentally demonstrate that this is the case. The mes genes function in the soma (Ross and Zarkower, 2003). It has also been shown that loss of gene activity in the somatic gonad can result in enhancement of the glp-1(ar202) tumorous germline phenotype (McGovern et al., 2009). Therefore, the authors should show that the mes gene mutant enhancement of glp-1(ar202) is germ cell autonomous, which is required based on the mechanism proposed. Similarly, the authors use RNAi of Notch upregulated genes to substantiate the argument that the genes are relevant for germ cell proliferation. While data from others has shown that some of the identified genes function in the germline (for example, Kershner et al., 2014; Doyle et al., 2000) it is also well known that loss of function of genes that function only in the soma can result in reduced proliferation (for example, Dalfo et al., 2012). Note that for utx-1, its function in reprogramming is interesting whether it acts in the germline or the soma, although models for its action would be different.*

To address this valid concern, we used the *glp-1(ar202); rrf-1(pk1417)* strain to re-screen *mes* genes and several enhancers/suppressors for germ cell autonomy. The *rrf-1* mutant strains have impaired somatic RNAi response, while the germline RNAi response is still robust (Sijen et al., 2001).

While some enhancers, such as *mbk-1* and B0416.5 seem to work from the somatic tissues (i.e. enhance the tumorous phenotype *in glp-1(ar202)* but not in *glp-1(ar202); rrf-1(pk1417)* mutants), other enhancers and suppressors, such as *puf-9*, are germ cell autonomous (see **F**[igure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Importantly, while *mes-2* and *mes-3* RNAi knockdowns were not very efficient (this has been observed in the lab before) and did not enhance the tumorous phenotype in either strain, RNAi-mediated depletion of MES-6 did enhance the phenotype in both *glp-1(ar202)* and *glp-1(ar202); rrf-1(pk1417)* strains. Thus, while there may be a somatic role for some of the enhancers or suppressors, the genetic interaction between GLP-1 and PRC2 is autonomous to the germline.

*3) The authors conclude that the GeCo phenotype requires Notch signaling, independent of proliferation. To be confident in the conclusion, the following issues should be addressed.*

*A) As lag-1 is the transcriptional effector of Notch signaling in C. elegans, [Figure 1C](#fig1){ref-type="fig"} does not give confidence that the lag-1 RNAi is working as the lag-1 RNAi should cause the glp-1 gain of function germ cells to enter meiosis, resulting in fewer germ cells and a different germline morphology compared to the mock treated (Berry et al., 1997).*

As pointed out, efficient depletion of LAG-1 will result in precocious differentiation of germ cells or suppress *glp-1* gf tumors. Indeed, *lag-1* RNAi was our control in the screen for *glp-1* gf tumor suppressors. However, a weaker *lag-1* RNAi was precisely the strength of our experiments, separating the effect on GeCo from the effect on proliferation. Our protocol involved *lag-1* RNAi only after hatching (P0 RNAi). By this, we bypassed the L1 lethality as well as the *glp-1(lf)-*like phenotype (loss of mitotic germ cells). Additionally, our use of double RNAi combinations (either with control vector or *lin-53* RNAi) in the *lag-1* assay effectively diluted the RNAi 1:1. Thus, we did not observe a fully penetrant *lag-1* phenotype for germ cell proliferation. Avoiding the *glp-1(lf)-*like phenotype was important, since we showed previously that the *glp-1(lf)* mutant background results in the loss of GeCo (Tursun et al. 2011). We apologize that we failed to explain this sufficiently. We state now explicitly in the Results section that "We exposed animals only after hatching to *lag-1* RNAi in order to avoid sterility\[...\]"

*B) From the images in [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, it appears that the HU treatment may have not been effective. HU should inhibit mitosis in the germ line, leading to fewer germ cell nuclei, and it should induce cell cycle arrest, leading enlarged germ nuclei. Although the HU image in [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} shows a lack of Edu positive nuclei, there is no evidence of enlarged germ cell nuclei or of reduced germ cell number, which is expected for HU treatment (see [Figure 4](#fig4){ref-type="fig"} in Gartner et al., 2004). The control for HU treatment is also not adequately explained.*

The protocol by Gartner, 2004 uses a 12 h incubation and subsequent EdU staining, which results in both, loss of EdU staining and the enlargement of germ cells. We have performed a new experiment shown in the [Figure 1---figure supplement 3C](#fig1s3){ref-type="fig"}using 12 h incubation with HU. We can see the enlargement of nuclei based on DAPI as described by Gartner, 2004 and Fox et al., 2011. We also performed H3Ser10ph (pH3) antibody staining and the loss of pH3 staining in the HU treated *glp-1(gf)* germline suggests that the germ cells undergo cell cycle arrest, indicating that HU treatment is, also in our hands, effective.

Importantly, Fox et al. 2011 have described that five hours of HU treatment are sufficient to abolish EdU staining, while germ cells do not yet enter a premeiotic stage. In a previous study using the exact same conditions, we could see the depletion of EdU incorporation but no obvious nuclei enlargement after 5 h (Patel et al. 2012). Therefore, we decided to use a 5 h exposure for imaging the cell cycle arrest in our original [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} panel B. While we cannot see obvious changes in germ cell nuclei size in the *glp-1(gf)* background after 5 h, we are confident that we have effectively induced cell cycle arrest by that time. We have further clarified our experimental procedure in Materials and methods / Cell cycle arrest by HU treatment and EdU staining.

*C) What developmental or cell cycle state are the germ cells with more or less Notch activity? This is important since Notch regulates the proliferative state of germ cells. Cells that are pre-meiotic may not be able to convert readily compared to proliferative germ cells. Note that this is independent of cell numbers, but relies on markers and morphology of the germ line. Conversely, in the HU block experiment, do the germ cells enter the meiosis pathway?*

We agree that GeCo diminishes when germ cells prematurely enter meiosis as we have shown before using the *glp-1(lf)* background (Tursun et al., 2011). The *glp-1(lf)* background is known to cause a premature entry into meiosis while *glp-1(gf)* causes a tumorous germ line due to increased proliferation and expansion of the meiotic zone. The tumorous germlines of *gld-1 gld-2* and of *gld-1 gld-2; glp-1(lf)* mutants have been characterized previously by Kadyk et al., 1998 and Hansen et al., 2004 using pH3, REC- 8, and HIM-3 antibodies. While wild-type germlines or *glp-1(lf)* germlines show 100% entry into meiosis, in the double or triple mutants, only 10 -- 20% of cells express early meiotic markers. This argues against the possibility that the loss of GeCo in *gld-1 gld-2; glp-1(lf)* triple mutant germlines is caused by increased meiotic entry because these cells actually barely enter into meiosis. We added this information to the revised manuscript.

*D) Although they should be related, the assessment of total germ cell number is not a measure of mitotic germ cell number, which is the key measure of proliferation. To determine whether the increase in conversion is a consequence of an increase in number of mitotic germ cells, the authors should quantify the number of mitotic germ cells (e.g., using phospho histone H3 staining) rather than total germ cell number.*

In order to disentangle whether 'increased proliferation' versus 'Notch signaling per se' is required for GeCo enhancement, we made use of the triple mutant background *gld-1 gld-2; glp-1(lf),* in which germ cells proliferate independently from GLP-1. This strain has been extensively documented to have a tumorous germline due to over-proliferation of the germ cells (Kadyk et al., 1998; Hansen et al., 2004; Fox et al., 2011). As shown in [Figure 1D](#fig1){ref-type="fig"} and [Figure 3B](#fig3){ref-type="fig"}, GeCo is almost lost in this triple mutant due to the absence of GLP-1. Hence, an increase in mitotic germ cells is not sufficient to result in the increase of conversion. Also, inhibiting the cell cycle with HU (which abolishes PH3-positive cells as shown in [Figure 1---figure supplement 3C](#fig1s3){ref-type="fig"}using phospho histone H3 staining) did not abolish GeCo, which suggests that the GLP-1 dependent enhancement is cell cycle independent.

*4) It would improve the paper to show a stain of H3K27me3 in the different cellular environments (Notch single and triple mutants) and to compare the location of H3K27me3 with locations that can respond to heterologous regulators.*

Based on communication with the Editor, we have performed H3K27me3 staining of gonads from different *glp-1* backgrounds. We did not detect any obvious changes in the global staining, consistent with GLP-1-dependent activation of a subset of PRC2-repressed genes. We provided this data in the new [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}.

*5) H3K27me3 might be predicted to silence transgenes introduced into worms, such as those involved in reprogramming. The authors should check the level of CHE-1 expression in the different cellular environments to make sure that the changes they track reflect the response of the tissue and not the expression of the inducer.*

To address this valid concern, we performed HA antibody staining for the 3xHA-tagged CHE-1 protein, which is being induced after heat-shock treatment in the different genetic backgrounds. We could not detect obvious changes in the induction of CHE-1::3xHA in the germlines of the different genetic backgrounds. Hence, the different effects on GeCo does not seem to be due to changes in the CHE-1 expression levels. We provide this data in the new [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}.

*6) The authors should improve the citations for previous C. elegans studies on Notch, PRC2, and reprogramming in C. elegans (e.g. from the Mango, Rothman, Krause, Priess labs such as Djabrayan et al., Genes & Development, 2012, Yuzyuk et al., Dev Cell, 2009).*

We apologize for incorrect citations and have corrected them throughout the manuscript.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below. Two are particularly important:*

*1) Your new experiments do not convincingly show that the interaction between Notch and PRC2 is germ line autonomous, so it remains uncertain where PRC2 and utx-1 are acting in glp-1(ar202) proliferation and conversion into neurons. Gene activity in the soma can modify glp-1(ar202) overproliferation in the germline.*

*2) Second, the conclusion that UTX-1 is a germ line target of Notch is not convincing.*

*These and the other points raised in the attached reviews all need to be addressed, either by experiments or by changing your text. Please note that we can offer no further opportunities for additional work or modification thus the binding decision must be made on your next revised submission.*

*Additionally, points in your paper overstated or incorrect as described in the reviews. For example, Vandamme et al. 2012 did not show endogenous UTX-1 expression in the germ line, contrary to what is stated in your paper. In other places there is insufficient information provided to allow readers outside of the immediate field to understand what is already known and what then is an expected result.*

As explained in our detailed response to the Reviewers, we thoroughly re-wrote the manuscript to eliminate errors, overstatements, and to improve clarity. As for the two major points, we could answer them by improving writing and performing a new experiment.

Firstly, while using the somatic RNAi-deficient *rrf-1* mutant to probe germline autonomy has limitations, which we now explain, we can use this background to eliminate the possibility, brought up by Reviewer 1, that the examined effects originate from the somatic gonad. As published by Kumsta and Hansen 2012, RNAi is in fact defective in the somatic gonad, including in the distal tip cell (DTC), allowing this type of analysis. We now provide new data, using the *rrf-1* background, supporting the germline- autonomy of UTX-1 in reprograming. Nevertheless, as requested by Reviewers, we have softened our conclusions as explained below.

Secondly, while indeed Vandamme et al. 2012 did not show the germline expression of *utx-1* -- we are sorry for this inaccuracy -- this was most likely so because extrachromosomal arrays, which they used to express UTX-1, are typically silenced in the germline. In fact, one of our supplemental figures showed exactly the germline expression of single copy-integrated, FLAG and GFP tagged, rescuing UTX-1, strongly arguing that the UTX-1 protein is normally expressed in the germline. We suspect this data was misunderstood because of unclear labeling, which we have now changed, as explained below. Finally, by using the *utx-1* promoter-driven reporter, we showed that the expression of this reporter in the germline responded to the alterations in either PRC2 or GLP-1/Notch.

Our new data on UTX-1-dependent reprograming in the *rrf-1* background, combined with the germline expression of tagged, rescuing UTX-1, and the *utx-1* promoter reporter studies, corroborate now the notion that UTX-1 functions in the germline. Nevertheless, we were careful to avoid overstatements and discussed alternative scenarios, as explained below.

*Reviewer \#1:*

*The investigation of the cell cycle vs Notch effects is carefully done and convincing.*

*The question of cell autonomy is not convincing ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"} and [Figure 5](#fig5){ref-type="fig"}). In particular:*

*The authors use rrf-1 to address whether genes function within the germ line. The logic is that a germline autonomous regulator should not be perturbed by the addition of an rrf-1 mutation. This is a weak line of reasoning as rrf-1 is required in some somatic tissues but not others: See Kumsta and Hansen 2012.*

We thank the Reviewer for pointing this out. Indeed, while the *rrf-1* mutation was used by others to examine germline autonomy (for example Wang et al. 2012, Developmental Dynamics; Killian and Hubbard 2004, Development; Chen and Greenwald 2015, Genes Genomes Genetics; Fox et al. 2011, Development), the study by Kumsta and Hansen reported ongoing RNAi in the intestine, and residual RNAi in some hypodermal cells.

Importantly, they confirmed deficient RNAi in the somatic gonad, including the distal tip cell (DTC). Thus, while this approach is not perfect, we still consider it as our best option to address germline autonomy. Nevertheless, to avoid overstatements, we now explain the limitation of this assay.

In the paragraph "GLP-1~Notch~ activates genes mainly on X chromosomes":

"While some of these genes may function autonomously in the germ line, others could affect the germ line indirectly from the soma. \[...\] While depleting most candidates in the *rrf-1* background had similar effects on the germ line as in the wild type (suggesting germ line- autonomous function), in some cases the effects were abolished, suggesting that these genes function in the soma ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}, [Figure 2--source data 1](#SD2-data){ref-type="supplementary-material"})."

In the paragraph "UTX-1 is required for GLP-1~Notch~-mediated GeCo enhancement": "Because UTX-1 was suggested to effect gonadal development by functioning in the somatic gonad (Vandamme et al. 2012), we re-examined GeCo efficiency upon *utx-1* RNAi in the *rrf-1 (pk1417)* background. \[...\] Because the suppression of GeCo upon *utx-1* RNAi was observed also in the *rrf-1* background, UTX-1 does not seem enhance GeCo by functioning in the somatic gonad ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"})."

In addition, mes-2 looks affected by rrf-1 mutations. So is this actually a germ-line role of PRC2? Or could it be somatic? And why do mes-3 and mes-6 look different from mes-2?

We apologize for the confusion. Apparently, our remark in the legend that, in this experiment, RNAi against *mes-2* and *-3* were ineffective, did not stand out. Since MES- 2, -3 and --6 function in a complex, and to avoid confusion, we have removed now the *mes-2* and *--3* RNAi data from the graph and re-wrote the legend accordingly (see the modified [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}).

*rrf-1 appears to modify the tumorous phenotype on its own. Why do rrf-1 mutants suppress glp-1 Tumors?*

This indeed appears to be the case, perhaps indicating a role for somatic endoRNAi. We presented the *glp-1(gf)* single mutant data nonetheless, to show that depleting chosen genes by RNAi had the expected effects on germline tumors (enhancement or suppression). However, the main point of this experiment was to compare the effects between different RNAi conditions in the *rrf-1* background. So, to avoid confusion, we decided to split the graphs between *glp-1(gf)* and *glp-1(gf); rrf-1* backgrounds (though we still remark in the legend to [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"} that the tumors were affected in the *rrf-1* background for an unknown reason):

"We observed that, for an unknown reason, the *rrf-1(pk1417); glp-1(ar202)* double mutants were less likely to produce tumors at the semi-permissive temperature of 20°C."

*Finally, it is unclear how the authors are calling the cut off for germline autonomous vs. somatic effects. Not only for mes-2 but for all genes.*

With the caveat of the residual RNAi in the intestine, we considered an RNAi-induced effect to indicate germline autonomy when the effect was observed in both *glp-1(gf)* and *glp-1(gf); rrf-1* backgrounds. If the effect was observed in only the *glp-1(gf)* background (but not the *glp-1(gf); rrf-1* background), we considered it indicative of a somatic effect. Clearly, with increased numbers of animals, we would be able to evaluate additional borderline cases and provide statistics. However, *glp-1(gf)* animals grow very slowly (need to be propagated at 15º), so performing more replicates was, due to the revision deadline, not doable. While we may have missed minor effects, we would like to point out that the main purpose of the experiment was to demonstrate that somatic effects may play a role for *s*ome of these genes, which is the case, and that, for PRC2, somatic effects do not play a major role (which we show for *mes-6*). We hope that restructuring the figure and our explanations will satisfy the Reviewer. We now emphasize that some of the Notch activated genes may function in the soma in the paragraph "GLP-1~Notch~ activates genes mainly on X chromosomes":

"While some of these genes may function autonomously in the germ line, others could affect the germ line indirectly from the soma. \[...\] While depleting most candidates in the *rrf-1* background had similar effects on the germ line as in the wild type (suggesting germ line- autonomous function), in some cases the effects were abolished, suggesting that these genes function in the soma ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}, [Figure 2--source data 1](#SD2-data){ref-type="supplementary-material"})."

*A simpler way to address this question would be to express a rescuing construct in the germ line alone. E.g. a mini Mos construct. This is most critical for utx-1, in my opinion.*

We would love to perform this experiment, and have tried hard to achieve a germline specific rescue. Unfortunately, *utx-1* is an essential gene. Therefore, expressing a rescuing *utx-1* construct only in the germline will lead to severe developmental defects of the animals due to the lack of *utx-1* in other tissues (Vandamme et al. 2012, [Figure 1E](#fig1){ref-type="fig"}). Nonetheless, and as stated in our previous response letter, we did try to express *utx-1* from *pie-1* or *gld-1* promoter but the animals turned sterile. Therefore, we resorted to the use of the *rrf-1* background. In *rrf-1* animals, neither the somatic gonad nor the DTC are able to stage an RNAi response. This is important with regard to the concern below.

While this approach has certain limitations -- for example, *rrf-1* worms are able to stage an RNAi response in the intestine -- it is the best we can do to investigate the autonomous versus non-autonomous roles of *utx-1* in GeCo (this new data is now shown in [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}).

*The conclusion that UTX-1 acts in the germ line is also not convincing for three reasons.*

*First, Seelk et al. use the promoter of utx-1 with a histone GFP readout ([Figure 5](#fig5){ref-type="fig"}). While this shows changes in glp and mes mutants, it is convincing with regard to UTX activity because the germ line relies heavily on post-transcriptional regulation. To ensure that the protein reflects RNA levels, the authors need to look at the endogenous protein or a single copy, rescuing reporter that has the whole protein and regulatory sequences.*

We would like to point out that this experiment has been already done ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). We expressed a single copy-integrated, FLAG and GFP-tagged UTX-1 protein from the endogenous promoter and under the control of the endogenous *utx-1* 3\'UTR. This fusion protein rescued the *utx-1* mutant and was expressed in the germline in the same pattern as the *utx-1* promoter reporter. We realized that the labeling of this figure could have been misleading and changed it (from *putx-1::FLAG-GFP::utx-1*) to *\"putx-1::flag-gfp-tev::utx-1::utx-1 3'utr\".*

*Second, Vandamme 2012 argued that UTX-1 activity in the soma influenced the germ line, perhaps through the distal tip cell. The distal tip cell signals through the Notch pathway, so this is a reasonable idea.*

As discussed above, Kumsta and Hansen, 2012 showed that RNAi is defective in the somatic gonad, including DTC, in *rrf-1* mutants. We now show in [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"} that *utx-1* RNAi in the *rrf-1* background still inhibited GeCo , arguing against a role for UTX-1 in DTC or other cells of the somatic gonad.

*Third, Vandamme 2012 did not show endogenous UTX-1 expression in the germ line, as stated by Seelk et al.*

We apologize for this obvious mistake. Indeed, Vandamme et al., 2012 showed with antibody staining that UTX-1 is present in the germline precursor cell at the 4-cell stage. For other tissues, they used extrachromosomal arrays, which, as a rule, are silenced in the germline. With the citation removed, the paragraph "GLP-1~Notch~ and PRC2 regulate

expression of the H3K27 demethylase UTX-1" now reads:

"To test the potential expression of *utx-1* in the germ line, we constructed a strain expressing single copy-integrated, FLAG and GFP-tagged, functional UTX-1 (expressed from the endogenous *utx-1* promoter under the control of endogenous *utx-1* 3\'UTR). We found that this protein was indeed expressed in the germline ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"})."

*The key question is whether UTX and H3K27me3 function in the germ line and downstream of Notch to control reprogramming via target gene regulation. It may be that some events occur in the soma, so I don\'t think the authors need to test everything for cell autonomy, but utx-1 would be useful, particularly given previous publications suggesting at distal tip cell focus.*

As discussed above, Kumsta and Hansen, 2012 showed that RNAi is defective in the DTC in *rrf-1* mutants. We now show in [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"} that *utx-1* RNAi in the *rrf-1* background inhibited GeCo enhancement, arguing against a role for UTX-1 in DTC (or other cells of the somatic gonad).

*The H3K27me3 stains appear to have been done without controls, so it is impossible to judge if there are any changes in different strain backgrounds. (If there were, it would be more convincing that utx was acting in the germ line.) A well-controlled experiment would include an on-slide control (e.g. a marked N2) and a germline control (e.g. histone H3). The ratio of H3K27me3:H3 would give an indication of whether levels are changing.*

We would like to point out that we did include a wild-type control ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). The stainings were performed independently by both Ciosk and Tursun labs, using whole worms or dissected gonads. The wild-type samples were not stained on the same slide as mutants, but were processed in the same batch and staining was always consistent. The genomic data suggested that increased GLP-1~Notch~ signaling actives a subset of PRC2-repressed genes, so the purpose of this experiment was to confirm that there was no global loss of H3K27me3 upon increased GLP-1~Notch~ signaling. Indeed, we found that, in the tested mutants, the levels and overall appearance of H3K27me3 were not obviously altered compared to controls.

*References to be added:*

*Introduction, second paragraph: add Horner et al., 1998 as one of the first examples of reprogramming in an intact organism and of timing of competence.*

Introduction, second or third paragraph: add Yuzyuk 2009 for PRC2 -dependent termination of plasticity and promotion of cell fate stabilization.

*Introduction, third paragraph: add Maures 2011, Jin 2011, maybe Vandamme 2012 for identification of utx-1 as a regulator of H3K27me3.*

We added these citations at the suggested positions.

*Reviewer \#2:*

*A number of changes need to be made to the manuscript so that the results and possible conclusion are more transparent.*

1\) Paragraph with heading "Both GLP-1^Notch^ and PRC2 regulate expression of the H3K27 demethylase UTX-1":

*A) The authors should first explain what is the expected expression pattern for a GLP-1 transcriptional target, based on the known and experimentally validated direct transcriptional targets of GLP-1 Notch in the gonad, lst-1 and sygl-1, described in Kershner et al. 2015. The failure to do so makes the paper hard to understand for readers outside the immediate C. elegans field.*

We re-wrote this paragraph and, before describing the *utx-1* expression pattern, introduce the patterns of *sygl-1* and *lst-1*, as suggested:

"With both the UTX-1 fusion protein and the putx-1 reporter, we expected expression patterns similar to that of other reported GLP-1~Notch~ target genes (Lamont et al. 2004; Lee et al. 2006; Kershner et al. 2014). \[...\] By contrast, both the UTX-1 fusion protein and the *putx-1* reporter were little or not expressed in the distal-most, proliferative part of the germ line ([Figure 5A-C](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"})."

*B) The expected pattern based on the work of Kershner et al., 2015, is that GLP-1 dependent transcripts are limited to the distal most 5 to 10 cell diameters, consistent with ligand expression limited to the distal tip cell. The authors interpretation of the putx-1::gfp ([Figure 1A](#fig1){ref-type="fig"}) and putx-1::FLAG-GFP::utx-1 ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) is that there is weak expression in the distal-most region of the germline where GLP-1 targets are expected to be expressed. However, this reviewer cannot see any putx-1 GFP signal above background, and this view is supported by the absence of mRNA in the distal-most germline from the in situ hybridization experiments in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Therefore, the sentence \"Consistent with the expression patterns of the endogenous utx-1 (Vandamme et al. 2012) and of a GFP used, functional utx-1 transgene ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), the utx-1 reporter was weakly expressed in the distal-most, proliferative part of the germline ([Figure 5A-C](#fig5){ref-type="fig"}).\" should be changed to indicate that there is \"little or no expression in the distal-most, proliferative part of the germline\".*

This sentence has been modified accordingly:

"By contrast, both the UTX-1 fusion protein and the *putx-1* reporter were little or not expressed in the distal-most, proliferative part of the germ line ([Figure 5A-C](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"})."

*C) The sentence \"However, a similar expression pattern has been reported for another reported GLP-1Notch target gene, lip-1 (Hajnal and Berset 2002; Lee et al. 2006).\" should be removed. Hajnal and Berset 2002 showed that lip-1 is a lin-12 transcriptional target in vulval development, with no information on glp-1 or the germline. Lee et al. 2006 did not perform the glp-1 dependence experiment comparing gld-1 gld-2 with gld-1 gld-2; glp-1, which the authors in this manuscript performed, and thus it is uncertain if lip-1 is a germline target of GLP-1 in distal-most germ cells.*

This sentence has been removed, as requested. We mention now the expression pattern of *lip-1* in the Discussion, citing Lee et al., 2006.

*D) In the first two paragraphs of the subsection "UTX-1 is required for GLP-1^Notch^-mediated GeCo enhancement". There is no evidence that GLP-1 signaling occurs in the medial/proximal gonad, as GLP-1 protein is not found in this region (Crittenden et al., 1994). Therefore, the expression of the 33 genes indicated is either an indirect consequence of GLP-1 signaling (another transcription factor that is transcribed in the distal-most germline stem cells in response to GLP-1 signaling which then acts to induce transcription much later in development, in pachytene cells) or is not regulated by GLP-1 signaling at all. The sentence needs to be changed to indicate that the observed expression is not consistent with direct GLP-1 transcriptional regulation.*

The sentence has been changed as recommended:

\"When examining the existing mRNA hybridization patterns of GLP-1~Notch~-activated and PRC2-repressed genes (33 genes), we noticed that half of these (18, all X-linked) are similarly expressed in the medial and/or proximal, but not the distal-most, gonads ([Supplementary file 2](#SD6-data){ref-type="supplementary-material"}), arguing against direct transcriptional activation of these genes by GLP-1~Notch~ in the wild type.\"

*2) In the subsection "Both GLP-1^Notch^ and PRC2 regulate expression of the H3K27 demethylase UTX-1". \"Deleting those sites drastically reduced reporter expression in the medial and proximal portions of the gonad ([Figure 5C](#fig5){ref-type="fig"}).\" [Figure 5C](#fig5){ref-type="fig"} indicates that the decrease is at most 25%. The sentence should be \"Deleting those sites reduced reporter expression by approximately 25% in the medial and proximal portions of the gonad ([Figure 5C](#fig5){ref-type="fig"}).\"*

The sentence has been changed as recommended:

\"\[...\]the activation of the *utx-1* promoter by Notch signaling was depended on the putative LAG-1/CSL binding sites within the promoter (Yoo et al. 2004), as deleting those sites reduced reporter expression by approximately one-fourth ([Figure 5C](#fig5){ref-type="fig"}).\"

*3) The last paragraph of the subsection "Both GLP-1^Notch^ and PRC2 regulate expression of the H3K27 demethylase UTX-1".*

*\"Overall, our observations suggest that PRC2 and GLP-1^Notch^ signaling have antagonistic effects on utx-1 transcription. However, the endogenous levels of GLP-1^Notch^ signaling are apparently insufficient to overcome PRC2-mediated repression in the distal part of the gonad\" does not emphasize the findings in the manuscript and should be rewritten in the following way:*

*\"Overall, our observations suggest that PRC2 and GLP-1^Notch^ signaling have antagonistic effects on utx-1 transcription that can be observed in a PRC2 mutant background. However, in wild type the endogenous levels of GLP-1^Notch^ signaling are apparently insufficient to overcome PRC2-mediated repression in the distal part of the gonad\".*

This paragraph has been rephrased as suggested:

"Summarizing, based on the observations in mutant backgrounds, PRC2 and GLP-1~Notch~ signaling have antagonistic effects on *utx-1* transcription. However, in wild type, the endogenous levels of GLP-1~Notch~ signaling are apparently insufficient to overcome PRC2-mediated repression of *utx-1* in the distal-most part of the gonad."

*4) Discussion. While the sentence \"This suggests that the identified set of genes may contain additional physiological GLP-1Notch targets.\" may be true, of the genes analyzed in this manuscript, none have been shown to be convincing GLP-1^Notch^ targets in wild type animals.*

*The Discussion should instead focus on their novel findings -- that PRC2 is apparently acting antagonistically to prevent certain GLP-1^Notch^ targets from being expressed in the germline, which makes sense as it is likely important to block the expression of some somatic GLP-1 targets from being expressed in germ cells, and that these include utx-1 which promotes reprogramming.*

We have re-written the Discussion, according to these suggestions, to our best ability.

*Reviewer \#3:*

*I think in general the study stands up as providing evidence that there is some antagonism between Notch activation and PRC2-mediated repression of genes, and that enhancement of Notch activity in germ cells yields similar transcriptional consequences to loss of PRC2 repression in germ cells -- enhanced X-linked gene expression. Similarly, these conditions also both make it easier to drive germ cells towards somatic differentiation upon ectopic activation of somatic fate drivers, such as che-1.*

*The question still stands whether this is informative for either normal germ cell development or for understanding the balance of activation and repression controlling early embryo development or programming/reprogramming.*

We are happy to hear that our Reviewer likes the evidence we provide for the antagonistic relationship of Notch and PRC2 in the germline.

As also requested by Reviewer 2, the Discussion now hopefully states clearly that, at this point, the connection to the wild-type development remains an open question.

*I think it\'s clear that the processes studied are artificial in terms of germ cell development -- but not entirely so. I think the authors do show that the balance of Glp-1 signaling and PRC2 repression are essential for normal germ cell development. I also think they\'ve shown they can uncouple some of the Glp-1-dependent effects from proliferation phenotypes. This probably underlies the differences in absolute phenotypes between Glp-1 gof and PRC2 mutants (which are presumably maternally rescued mutants): proliferation defects in the former compared to little visible defects in the maternally rescued germ cells. It\'s formally interesting that raising the level of Notch activity has the same effect on transcriptional regulation as lowering PRC2 activity in these cells. It\'s interesting that this seems to be separate from any need for proliferation to be dysregulated.*

*I think the authors have adequately addressed the technical concerns about this conclusion.*

*There still is a bit of what I view as semantic issues with how some things are phrased that can be over-interpreted by the reader, or may indeed still be overstatements by the authors:*

*For example, the subsection "GLP-1^Notch^ and PRC2 have antagonistic functions in the germline" states \"that, in the C. elegans gonad, specific PRC2-repressed genes are activated via GLP-1^Notch^ signaling.\" This certainly implies that glp-1 activation of genes like utx-1 is part of normal germ cell function, which is unlikely to be true.*

We have rephrased this sentence to: \"... suggests that increased GLP-1 signaling can induce expression of specific PRC2-repressed genes.\"

*Lastly, the description of the mes mutants used needs to be clarified. I am assuming that when the authors are referring to mes-2(bn11) mutants, etc. they are actually referring to the F1 maternally rescued homozygote offspring (e.g., M Z ). It is important to clarify that these animals and their germ cells are not completely devoid of a history of PRC2 activity, which is why they have germ cells to count and look at in the first place. Absent maternal MES protein, there wouldn\'t be but a few dying germ cells in the adult gonads to look at.*

We thank the Reviewer for pointing this out. Indeed, we used M Z- animals. We now indicate it in the main text:

\"At 20°C, both the temperature-sensitive gain-of-function *glp-1(ar202)* and the homozygous loss-of-function *mes-2(bn11)* mutants, derived from heterozygous mothers providing maternal MES-2 (*mes-2* M Z- mutants), were viable and produced gonads with nearly wild-type appearance. The double *mes-2* M Z-; *glp-1(ar202)* mutants, however, displayed distal and proximal tumors at the same temperature\[...\]\"

\"\[...\]we first determined putative PRC2 targets by expression analyses on isolated wild- type, M Z- *mes-2* or *mes-6* mutant gonads...\"

\[...\]in the legend to [Figure 2](#fig2){ref-type="fig"}:

\"The *mes-2(bn11)* M Z- single mutant gonads have wild-type appearance at 20°C.\"

\"At the same temperature, *mes-2(bn11)* M Z-; *glp-1(ar202)* double mutants developed extensive germ line tumors in 32/32 of the examined gonads.\"

\"The plots correlate changes in gene expression in M Z- *mes-2* mutants with changes in gene expression changes in M Z- *mes-6* mutants.\"

\[...\]and in the in the legend to [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}:

\"In M Z- *mes-6(bn66)* mutants, *utx-1* is upregulated throughout the gonads compared to the control wild-type gonads.\"
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